Page last updated: 2024-08-24

cephalosporin c and Infections, Pseudomonas

cephalosporin c has been researched along with Infections, Pseudomonas in 602 studies

Research

Studies (602)

Timeframe	Studies, this research(%)	All Research%
pre-1990	176 (29.24)	18.7374
1990's	73 (12.13)	18.2507
2000's	78 (12.96)	29.6817
2010's	154 (25.58)	24.3611
2020's	121 (20.10)	2.80

Authors

Authors	Studies
Bremmer, DN; Kline, EG; Nicolau, DP; Shah, S; Shields, RK	1
Benvenuti, MR; Borghesi, L; Franzetti, M; Luzzaro, F; Mauri, C; Moioli, G; Montoli, M; Piconi, S; Viaggi, V	1
DePestel, DD; DeRyke, CA; Garrison, MW; Harris, KA; Moise, PA; Pfaller, MA; Sader, HS; Shortridge, D	1
Horcajada, JP; López Montesinos, I; Montero, M; Sorlí, L	1
Carvalhaes, CG; Castanheira, M; Sader, HS; Shortridge, D	1
Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS	1
Angulo-Brunet, A; Campillo, N; Domene-Ochoa, S; Ferrer-Alapont, L; Grau, S; Horcajada, JP; López-Causapé, C; Luque, S; Montero, MM; Oliver, A; Padilla, E; Prim, N; Sorlí, L	1
Alcalde-Rico, M; Arias, CA; García, P; Khan, A; Martínez, JRW; Miller, WR; Moreno, MV; Munita, JM; Olivares-Pacheco, J; Rivas, L; Rojas, P; Wozniak, A	1
Chen, WT; DeRyke, CA; Kazmierczak, KM; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K	1
Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Fernández-Pérez, B; Fraile-Ribot, PA; Gato, E; González-Bello, C; Guijarro-Sánchez, P; Gutiérrez-Urbón, JM; Lasarte-Monterrubio, C; Oliver, A; Oviaño, M; Ruedas-López, A; Vallejo, JA; Vázquez-Ucha, JC; Velasco, D	1
Baylac, P; Bercot, B; Camelena, F; de Fontbrune, FS; Gras, J; Lafaurie, M; Molina, JM; Touratier, S; Valade, S; Villar-Fernandez, S; Xhaard, A	1
Cabot, G; Gomis-Font, MA; Juan, C; López-Argüello, S; Moyá, B; Oliver, A; Zamorano, L	1
Al Musawa, M; Alattas, M; Alfahad, W; Alfozan, A; Alghamdi, A; Alhameed, AF; Aljabri, A; Almangour, TA; Almohaizeie, A; Almuhisen, S; Alraddadi, BM; AlShahrani, FS; Binkhamis, KM; Damfu, N; Khuwaja, M; Qutub, M	1
Al-Alawi, MM; Ali, HE; Almutairi, AF; AlTurki, R; Bahabri, NM; Janah, SS; Khalil, S; Qutub, MO; Tashkandi, WA	1
Bennis, Y; Dubée, V; Jaubert, P; Luque-Paz, D; Mortaza, S; Wolff, M	1
Carratalà, J; Cuervo, G; González Laguna, M; Llop Talaveron, J; Padullés, A; Pérez-Recio, S; Ronda, M; Soldevila-Boixader, L; Tubau Quintano, MF	1
Csékó, AB; Gál, J; Hermann, C; Iványi, ZD; Mogyoródi, B	1
Chew, KL; Leong, Q	1
Ali, O; Cortes-Lara, S; Del Barrio-Tofiño, E; Goossens, H; Kluytmans, J; Köhler, T; Kumar-Singh, S; Lammens, C; López-Causapé, C; MacLean, RC; Malhotra-Kumar, S; Oliver, A; Paling, F; Ruzin, A; Timbermont, L; Torrens, G; van der Schalk, TE; Xavier, BB; Zamorano, L	1
Candel, FJ; González Del Castillo, J; Julián Jiménez, A; Matesanz, M	1
DeRyke, CA; Hilbert, DW; Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Wong, MT; Young, K	1
Canton, R; Doi, Y; Simner, PJ	1
Benítez-Cano, A; Grau, S; Luque, S; Navarrete-Rouco, ME; Roberts, JA; Sorlí, L	1
Adam, HJ; Baxter, MR; Bay, D; Karlowsky, JA; Lagacé-Wiens, PRS; Lynch, JP; Mulvey, MR; Schweizer, F; Walkty, AJ; Zhanel, GG	1
Antonelli, A; Brenciani, A; Brescini, L; Castelletti, S; Cirioni, O; D'Achille, G; Di Pilato, V; Fioriti, S; Giacometti, A; Giani, T; Giovanetti, E; Masucci, A; Mingoia, M; Morroni, G; Rossolini, GM	1
Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, PA; Galán-Sánchez, F; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Oliver, A; Rumbo-Feal, S; Vázquez-Ucha, JC	1
Castanheira, M; Collingsworth, TD; DeVries, S; Doyle, TB; Hubler, CM; Mendes, RE	1
Albarracín Orio, AG; Bonomo, RA; Colque, CA; Dotta, G; Feliziani, S; Hedemann, LG; Hickman, RA; K Johansen, H; Molin, S; Moreno, DM; Moyano, AJ; Smania, AM; Sommer, LM; Tomatis, PE; Vila, AJ	1
Abbara, D; Afaneh, L; Al Duhailib, Z; Al Qahtani, MM; Al Sulaiman, K; Aldhayyan, N; Askar, G; Dyab, N; Hakeam, HA; Islami, M; Mansour, R	1
Bachta, KER; Bertucci, HK; Brunzelle, JS; Gatesy, SWM; Hauser, AR; Lebrun-Corbin, M; Minasov, G; Ozer, EA; Pincus, NB; Rosas-Lemus, M; Satchell, KJF; Shuvalova, LA	1
Haines, RR; Hammer, KA; Putsathit, P; Tai, AS	1
Alekseeva, I; DeRyke, CA; Estabrook, MA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K	1
Baretta, V; Calore, E; Carraro, F; Cesaro, S; Colombini, A; Meazza, C; Muggeo, P; Onofrillo, D; Perruccio, K; Rosaria D'Amico, M; Zama, D	1
Dessein, R; Gosset, P; Kipnis, E; Le Guern, R; Nordmann, P; Poirel, L; Sadek, M	1
Gill, CM; Nicolau, DP	1
Alekseeva, I; DeRyke, CA; Hawser, SP; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K	1
Böhringer, N; Horst, J; Hübner, J; Kappler, M; Kolberg, L; Kresna, IDM; Liu, Y; Marner, M; Mettal, U; Meyer-Bühn, M; Mihajlovic, S; Schäberle, TF; von Both, U; Wang, L	1
Amara, M; Barraud, O; Bastide, M; Bernabeu, S; Bille, E; Bonnin, RA; Brun, CL; Cattoir, V; Corvec, S; d'Epenoux, LR; Degand, N; Dortet, L; Emeraud, C; Farfour, E; Fihman, V; Grillon, A; Guillard, T; Isnard, C; Jacquier, H; Janvier, F; Jousset, AB; Laurent, F; Lemonnier, A; Lomont, A; Merens, A; Mizrahi, A; Plouzeau, C; Ranc, AG; Soismier, N; Yin, N; Zahar, JR	1
Cabot, G; Khajehpour, M; Kim, K; Mark, BL; Oliver, A	1
Jia, P; Xu, Y; Yang, Q; Yu, W; Zhang, H; Zhu, Y	1
Arends, SJR; Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Shortridge, D	1
Akrich, B; DeRyke, CA; Hawser, SP; Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K	1
Aja-Macaya, P; Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Fernández-González, A; Galán-Sánchez, F; González-Mayo, E; Guijarro-Sánchez, P; Lada-Salvador, P; Lasarte-Monterrubio, C; Martínez-Guitián, M; Muíño-Andrade, M; Oliver, A; Rodríguez-Iglesias, M; Rumbo-Feal, S; Vázquez-Ucha, JC; Vela-Fernández, R	1
Gilboa, M; van Duin, D; Yahav, D	1
Hsueh, PR; Lee, YL	1
Bell, SC; Lamont, IL; Martin, LW; Patrick, WM; Ramsay, KA; Rehman, A; Wardell, ST; Winstanley, C	1
Hsueh, PR; Ko, WC; Lee, YL	1
Fujimori, T; Hagiya, H; Higashikage, A; Iio, K; Kakehi, A; Minabe, H; Okura, M; Otsuka, F; Yokoyama, Y	1
Cabot, G; Gomis-Font, MA; Oliver, A; Sastre-Femenia, MÀ; Taltavull, B	1
Faurholt-Jepsen, D; Jensen, PØ; Johansen, HK; Katzenstein, TL; Kolpen, M; Pressler, T; Qvist, T	1
Challa, HPR; Dubbudu, RR; Gupta, A; Kumar, LS; Reddy, PN; Sree, RA; Tirlangi, PK; Wanve, BS; Yadav, BS	1
Agyeman, AA; Boyce, JD; Bulitta, JB; Cortés-Lara, S; Figuerola, J; Fraile-Ribot, P; Franklyn, ERT; Gomis-Font, MA; Landersdorfer, CB; Lang, Y; Lee, WL; López-Causapé, C; Lucas, DD; Nation, RL; Oliver, A; Rogers, KE; Zhang, Y; Zhou, J	1
Abbott, IJ; Chang, CC; Dennison, A; Kostoulias, X; Peleg, AY; Spelman, DW; Wisniewski, J; Zisis, H	1
Egge, SL; Hakki, M; Lewis, JS	1
Al Musawa, M; Alanazi, MQ; Alassiri, D; Alfahad, W; Alghaith, J; Alharbi, A; Aljefri, D; Aljurbua, A; Almangour, TA; Almohaizeie, A; Almuhisen, S; Alsowaida, YS; Damfu, N; Ghonem, L; Khormi, Y	1
Clark, JR; Gu Liu, C; Maresso, AW; Nicholls, P; Terwilliger, A	1
Bakthavatchalam, YD; Bano, N; Dubey, D; Dubey, M; Imran, A; Jain, B; Kulshrestha, V; Mitra, S; Roy, M; Sangwan, P; Shah, TH; Veeraraghavan, B; Velmurugan, A	1
Bour, M; Da Silva, M; Jeannot, K; Landon, C; Plésiat, P; Vuillemin, X	1
Albur, M; Attwood, M; Griffin, P; Macgowan, AP; Noel, AR	1
Cosentino, F; Giannella, M; Viale, P	1
Bou, G; Cabot, G; Cortes-Lara, S; Del Barrio-Tofiño, E; López-Causapé, C; Martínez-Martínez, L; Oliver, A; Sánchez-Diener, I; Zamorano, L	1
Abdel Hadi, H; Abu Jarir, S; Al-Maslamani, MA; Bonomo, RA; Dousa, KM; Eltai, NO; Hassan, AAI; Hujer, AM; Ibrahim, EB; Jass, J; Omrani, AS; Sid Ahmed, MA; Soderquist, B; Sultan, AA	1
Cuesta, M; Gonzalez-Zorn, B; Hoefer, A; Ortega-Huedo, R	1
Bonomo, RA; Davis, SL; Dhar, S; File, TM; Gerlach, AT; Kaye, KS; Olson, S; Patel, TS; Perez, F; Pogue, JM; Puzniak, LA; Veve, MP	1
Clancy, M; Stevens, RW	1
Abdelraouf, K; Kidd, JM; Nicolau, DP	1
Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM	1
Aguilar, G; Blasco, ML; Calabuig, M; Carbonell, N; Colomina, J; Ezquer, C; Ferreres, J; Ferriols, R; Huerta, R; Juan, M	1
Cheng, S; He, J; Jia, X; Liu, H; Ma, W; Tian, X; Zou, H	1
Allan, RN; Cai, Y; Connett, GJ; Davies, JC; Faust, SN; Feelisch, M; Howlin, RP; Kelso, MJ; Rineh, A; Silva, DG; Soren, O; Webb, JS	1
Buonomo, AR; Gentile, I; Maraolo, AE; Mazzitelli, M; Torti, C; Trecarichi, EM	1
Alves, V; Cantón, R; Chaves, C; Diogo, J; Ferreira, R; García-Castillo, M; García-Fernández, S; Gonçalves, E; Melo-Cristino, J; Paixão, L; Pássaro, L; Pinto, MF; Ramalheira, E; Sancho, L; Silva, D; Vieira, AR	1
Buonomo, AR; Congera, P; Foggia, M; Gentile, I; Maraolo, AE; Parente, S; Scotto, R; Zappulo, E	1
Shields, RK	1
Abdulhamid, I; Ang, JY; Molloy, L; Srivastava, R	1
Kharat, AS; Khobragade, K; Palwe, S; Periasamy, H; Veeraraghavan, B	1
Cabot, G; Fernández-Esgueva, M; Fraile-Ribot, PA; Huarte, R; López-Calleja, AI; Mulet, X; Oliver, A; Rezusta, A	1
Juhász, E; Katona, K; Kristóf, K; Melegh, S; O'Neall, D; Szabó, J; Tóth, Á; Urbán, E	1
Amore, D; Anile, M; Bassi, M; Cagnetti, S; Carillo, C; D'Agostino, FG; De Giacomo, T; Diso, D; Mantovani, S; Mottola, E; Pagini, A; Pecoraro, Y; Poggi, C; Pugliese, F; Rendina, EA; Russo, G; Vannucci, J; Venuta, F	1
Cayô, R; Cuba, GT; Gales, AC; Kiffer, CRV; Nicolau, DP; Nodari, CS; Pignatari, ACC; Rocha-Santos, G; Streling, AP	1
DePestel, DD; Karlowsky, JA; Lob, SH; Motyl, MR; Raddatz, J; Sahm, DF; Young, K	1
Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H	1
Adamou, P; Antoniadou, A; Damala, M; Deliolanis, I; Fountoulis, K; Galani, I; Galani, L; Giamarellou, H; Karaiskos, I; Karantani, I; Kirikou, H; Kodonaki, A; Maraki, S; Markopoulou, M; Papadogeorgaki, E; Papoutsaki, V; Petinaki, E; Prifti, E; Souli, M; Tsiplakou, S; Vagiakou, E	1
Arends, SJR; Duncan, LR; Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM	1
Carvalhaes, CG; Duncan, LR; Flamm, RK; Sader, HS; Shortridge, D	1
Bisanti, A; Diaz, E; Martin-Loeches, I; Rodriguez, A	1
Bidell, MR; Lodise, TP; O'Donnell, JN	1
Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, PA; Galán-Sánchez, F; González-Bello, C; Lasarte-Monterrubio, C; Lence, E; Martínez-Guitián, M; Oliver, A; Rodríguez-Iglesias, M; Vázquez-Ucha, JC	1
Carniel, E; da Cunha, RSR; Dias, CG; Narvaez, GA; Perez, LRR	1
Forland, SC; Guerrero-Wooley, RL; Hino, G; Park, SH; Winans, SA	1
Avdic, E; Beisken, S; Bergman, Y; Cosgrove, SE; Posch, AE; Sharara, SL; Simner, PJ; Tamma, PD	1
Bookstaver, PB; Bouchard, J; Gould, AP; Hucks, J; Justo, JA; Nelson, D; Nicolau, D; O'Neal, M; Sheffield, M	1
Bacca, E; Bedini, A; Bianco, V; Cuomo, G; Franconi, I; Meschiari, M; Mussini, C; Orlando, G	1
Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Galán-Sánchez, F; González-Bello, C; Lasarte-Monterrubio, C; Oliver, A; Rodiño-Janeiro, BK; Rodríguez-Iglesias, M; Vázquez-Ucha, JC	1
Alves, V; Bou, G; Cantón, R; Cercenado, E; Chaves, C; Delgado-Valverde, M; Díaz-Regañón, J; Diogo, J; Ferreira, R; García-Castillo, M; García-Fernández, S; Gonçalves, E; Hernández-García, M; López-Mendoza, D; Melo-Cristino, J; Oliver, A; Paixão, L; Pássaro, L; Pinto, MF; Pitart, C; Ramalheira, E; Rodríguez-Lozano, J; Romano, J; Sancho, L; Silva, T; Tormo, N; Vieira, AR	1
Bhalodi, AA; Gamage, D; Humphries, RM; Oppermann, N; Shamsheyeva, A; Sikorski, A	1
Ibrahim, D; Jabbour, JF; Kanj, SS	1
Cohen, L; Finklea, JD; Jain, R; Nolan, PJ; Smith, TT	1
Al-Delaimi, MS; Yacoob Aldosky, HY	1
Blomquist, KC; Nix, DE	1
Asensio-Martín, MJ; Balandin, B; Ballesteros, D; Chicot, M; Fernández-Simón, I; Iranzo, R; López-Vergara, L; Martínez-Sagasti, F; Pérez-Pedrero, MJ; Pintado, V; Rodríguez-Serrano, D; Royuela, A; Ruiz de Luna, R; Sancho-González, M; Silva, A; Soriano-Cuesta, C	1
Bruno, C; Carmelitano, P; Castanheira, M; De Anda, C; Huntington, JA; Johnson, MG; Motyl, M; Rhee, EG; Yu, B	1
Epps, KL; Epps, QJ; Zobell, JT	1
Khan, S; Phe, K; Tam, VH	1
Arcay, RM; Cantón, R; Castillo, FJ; Cercenado, E; Cisterna, R; Díaz-Regañón, J; Gálvez-Benítez, L; González Romo, F; Hernández-Cabezas, A; López-Mendoza, D; Loza, E; Rodríguez-Lozano, J; Suárez-Barrenechea, AI; Tubau, F	1
Baccani, I; Bartalesi, F; Bartoloni, A; Borchi, B; Bresci, S; Cavallo, A; Ottino, L; Rossolini, GM	1
Sivashanmugam, K; Srivastava, P	1
Cooper, K; Gould, IM; Hijazi, K; Ironside, C; Okoliegbe, IN	1
Collings, H; Dillon, R; Enstone, A; Palmer, T; Puzniak, L	1
Murri, R; Sacco, E	1
Betthauser, KD; Kollef, MH; Lizza, BD; Micek, ST; Ritchie, DJ	1
Barrio-Tofiño, ED; Cortes-Lara, S; López-Causapé, C; Oliver, A	1
Akrich, B; Amode, A; Berthelot, A; Boutoille, D; Castan, B; Levy-Bachelot, L; Mackosso, C; Mathis, L; Mootien, J; Ruimy, R; Ruiz, F; Timsit, JF	1
Anstey, KM; Choi, L; Dawson, D; Kleinhenz, ME; Otani, IM	1
Baquero-Artigao, F; Calvo, C; Del Rosal, T; Gerig, N; Gómez-Gil, MR; Grasa, CD; Moreno, F; Ochoa Fernández, B; San Román Pacheco, S	1
Cortes-Lara, S; Del Barrio-Tofiño, E; Gomis-Font, MA; López-Causapé, C; Marco, F; Mulet, X; Oliver, A; Pitart, C; Vila, J; Zboromyrska, Y	1
Ebisui, A; Goto, R; Inose, R; Ishii, S; Ishikane, M; Kawabe, A; Koizumi, R; Kusama, Y; Muraki, Y; Ohmagari, N; Yagi, T	1
Cazorla-Poderoso, L; Huarte-Lacunza, R; Larrodé-Leciñena, I; López-Calleja, AI; Magallón-Martínez, A; Martínez-Álvarez, RM; Pereira-Blanco, O; Pérez-Moreno, M; Pinilla-Rello, A	1
Holland, P; Jahnke, N	1
Daragon, B; Fournier, D; Jeannot, K; Plésiat, P	1
Gatti, M; Pea, F	1
Brink, A; Chu, CY; Coetzee, J; Dimopoulos, G; Gill, CM; Moodley, C; Nicolau, DP; Opperman, CJ; Pournaras, S; Tenover, FC; Tickler, IA; Tootla, HD; Vourli, S	1
Cantón, R; García-Castillo, M; García-Fernández, S; Hernández-García, M; Pássaro, L	1
Aktaş, E; Alfouzan, W; Bourassa, L; Brink, A; Burnham, CD; Canton, R; Carmeli, Y; Falcone, M; Gill, CM; Kiffer, C; Marchese, A; Martinez, O; Nicolau, DP; Pournaras, S; Seifert, H; Thabit, AK; Villegas, MV; Westblade, LF	1
Abbo, LM; Adachi, J; Aitken, SL; Araos, R; Arias, CA; Bonomo, RA; Jain, R; Lichtenberger, PN; Miller, WR; Munita, JM; Nigo, M; Perez, F; Rakita, R; Rosa, R; Shelburne, S; Shimose, LA; Tran, TT; Wanger, A	1
Castanheira, M; Flamm, RK; Jones, RN; Rhomberg, PR; Sader, HS	1
Álvarez Lerma, F; Gracia Arnillas, MP; Grau, S; Mico García, M; Muñoz Bermudez, R; Recasens, L; Sorli, L	1
Berenson, CS; Kurtzhalts, KE; Manohar, A; Mergenhagen, KA	1
Béraud, G; Bouchand, F; Canouï, E; Davido, B; Dinh, A; Duran, C; Ferry, T; Hénard, S; Kernéis, S; Lazaro, P; Lebeaux, D; Wolff, M; Wyplosz, B	1
Bassetti, M; Castaldo, N; Givone, F; Peghin, M; Righi, E; Sartor, A	1
Borgia, G; Buonomo, AR; De Zottis, F; Di Renzo, G; Gentile, I; Maraolo, AE; Scotto, R	1
Epps, KL; Young, DC; Zobell, JT	1
Echols, R; Hoover, J; Matsumoto, S; Nakamura, R; Rittenhouse, S; Singley, CM; Tsuji, M; Yamano, Y	1
Cho, YL; Kim, HS; Kwak, JH; Oh, K; Oh, SH; Park, HS; Yun, JY	1
Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK	1
Chia, JH; Huang, CT; Lee, MH; Su, TY; Yang, CC; Ye, JJ	1
Grupper, M; Nicolau, DP; Sutherland, C	1
Borgia, G; Cascella, M; Corcione, S; Cuomo, A; De Rosa, FG; Gentile, I; Maraolo, AE; Nappa, S	1
Goodlet, KJ; Nailor, MD; Nicolau, DP	1
Chen, L; Kreiswirth, BN; MacVane, SH; Pandey, R; Steed, LL	1
Bhattacharjee, A; Chakravarty, A; Dhar Chanda, D; Ingti, B; Krishnatreya, DB; Maurya, AP	1
Becker, K; Bletz, S; Idelevich, EA; Mellmann, A; Schaumburg, F	1
Bodro, M; Marco, F; Martínez, JA; Soriano, A; Xipell, M	1
Hindler, JA; Humphries, RM; Miller, SA; Wong-Beringer, A	1
Cheng, S; Clancy, CJ; Cooper, VS; Doi, Y; Haidar, G; Hao, B; Nguyen, MH; Philips, NJ; Potoski, BA; Press, EG; Shields, RK; Snyder, D	1
Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D	2
Bassetti, M; Castaldo, N; Givone, F; Lechiancole, A; Livi, U; Maiani, M; Pea, F; Peghin, M; Righi, E; Sartor, A	1
Lodise, TP; Natesan, S; Pai, MP	1
Lasco, TM; Ledesma, KR; Skoglund, E; Tam, VH	1
Cabot, G; Fraile-Ribot, PA; Juan, C; Martín-Pena, ML; Mulet, X; Oliver, A; Pérez, JL; Periañez, L	1
Arcenillas, P; Boix-Palop, L; Calbo, E; Cuchi, E; Dietl, B; Gómez, L; González de Molina, FJ; Nicolás, J; Sánchez, I	1
Arena, F; Bassetti, M; D'Andrea, MM; Di Pilato, V; Giani, T; Henrici De Angelis, L; Pollini, S; Rossolini, GM	1
Adam, H; Baxter, M; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, P; Walkty, A; Zhanel, GG	2
Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS; Shortridge, D	1
Monogue, ML; Nicolau, DP	1
Bodro, M; Fresco, L; Marco, F; Martínez, JA; Paredes, S; Soriano, A; Xipell, M	1
Hussain, BM; Hussin, H; Phoon, HYP; Thong, KL	1
Hakki, M; Lewis, JS	1
Allworth, AM; Legg, A; McCarthy, KL; Roberts, JA; Stewart, A; Wallis, SC	1
Bassetti, M; De Rosa, FG; Del Bono, V; Giacobbe, DR; Grossi, PA; Menichetti, F; Pea, F; Rossolini, GM; Tumbarello, M; Viale, P; Viscoli, C	1
Almirante, B; Arévalo, Á; Campany, D; Escolà-Vergé, L; Ferrer, R; Larrosa, N; Len, O; Los-Arcos, I; Nuvials, X; Pigrau, C; Viñado, B	1
Caro, L; Huntington, JA; Long, J; Xiao, AJ	1
Chaves, F; Lora-Tamayo, J; Orellana, MÁ; Recio, R; Viedma, E; Villa, J	1
Alessa, MA; Alhokail, M; Alhossan, A; Alkholief, MA; Almangour, TA; Tabb, DE	1
Dunn, A; Plant, AJ; Porter, RJ	1
Finklea, JD; Hollaway, R; Jain, R; Le, J; Lee, F; Lowe, K	1
Jones, AL; Lee, AC	1
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G	1
Jiménez-Delgado, JD; Monterrubio-Villar, J; Rodríguez-Garrido, S	1
Asensio, J; Ayestarán, I; Colomar, A; Delgado, O; Díaz-Cañestro, M; Fraile-Ribot, PA; López-Causapé, C; Maciá, M; Martin-Pena, ML; Mulet, X; Murillas, J; Novo, A; Nuñez, B; Oliver, A; Pérez, JL; Periañez, L; Riera, M; Torres, V	1
Bahat-Dinur, A; El-Seid, S; Kaplan, D; Kraus, M; Peled, C; Tzvi-Ran, LR	1
Bonomo, RA; Chambers, HF; Chen, L; Domitrovic, TN; Evans, SR; Farmer, M; Fowler, VG; Hill, CB; Hujer, AM; Hujer, KM; Jacobs, MR; Kreiswirth, BN; Manca, C; Mediavilla, JR; Patel, R; Perez, F; Pitzer, KM; Tran, TTT; Wilson, BM	1
Galega, R; Greene, JN; Lee, GC; Quilitz, R; Shurko, J; So, W	1
Bassetti, M; Montravers, P	1
Dubois, V; Jayol, A; Kieffer, N; Nordmann, P; Ortiz De La Rosa, JM; Poirel, L	1
Abdou, A; Hassam, B	1
Henderson, A; McCarthy, KL; Paterson, DL; Tan, E	1
Artioli, S; Bassetti, M; Capone, A; Carannante, N; Castaldo, N; Cattelan, A; Cipriani, L; Coletto, D; Digaetano, M; Grossi, P; Losito, AR; Mastroianni, CM; Menichetti, F; Mussini, C; Nicolè, S; Peghin, M; Righi, E; Russo, A; Tascini, C; Tumbarello, M; Vena, A	1
Ariyasu, M; Beale, R; Den Nagata, T; Edgeworth, JD; Jones, A; Jones, P; Livermore, DM; Merante, D; Patel, S; Roberts, P; Vithlani, S; Wyncoll, D; Young, C	1
Abbara, S; Cherrier, P; Diamantis, S; Hodjat, K; Jochmans, S; Monchi, M; Pitsch, A; Vinsonneau, C	1
Fernández Esgueva, M; Ferrer Cerón, I; García-Lechuz Moya, JM; López-Calleja, AI; Morilla Morales, E; Nuñez Medina, R; Rezusta López, A; Sahagún Pareja, J; Viñuelas Bayon, J	1
Basak, GW; Saran, O; Sulik-Tyszka, B; Wróblewska, MM	1
Arena, F; Cassetta, MI; Contorni, M; Henrici De Angelis, L; Maglioni, E; Marchetti, L; Novelli, A; Rossolini, GM	1
Ariza, J; Benavent, E; El Haj, C; Gómez-Junyent, J; Murillo, O; Rigo-Bonnin, R; Sierra, Y; Soldevila, L; Torrejón, B; Tubau, F	1
Blázquez-Gamero, D; Brañas, P; Epalza, C; Flores, M; Grau, S; Martín-Cazaña, M; Olmedilla, M	1
Di Bonaventura, G; Fiscarelli, E; Gherardi, G; Linardos, G; Pompilio, A	1
Aitken, E; Gould, IM; Hijazi, K; Joshi, C; Oggioni, MR; Zamudio, R	1
DePestel, DD; DeRyke, CA; Gupta, V; Merchant, S; Murray, J; Puzniak, L; Srinivasan, A; Ye, G	1
Hishinuma, T; Kirikae, T; Shimojima, M; Tada, T; Uchida, H	1
Avery, LM; Nicolau, DP; Sutherland, CA	1
Akova, M; Albasanz-Puig, A; Araos, R; Bote, A; Brunel, AS; Calik, S; Carratalà, J; Del Pozo, JL; Drgona, L; García, E; Gomes, MZR; Gudiol, C; Hemmati, P; Herrera, F; Ibrahim, KY; Isler, B; Kanj, S; Kern, W; Maestro de la Calle, G; Manzur, A; Marin, JI; Márquez-Gómez, I; Martín-Dávila, P; Mikulska, M; Montejo, JM; Montero, M; Morales, HMP; Morales, I; Novo, A; Oltolini, C; Parody, R; Peghin, M; Puerta-Alcalde, P; Ruiz-Camps, I; Sipahi, OR; Tebe, C; Tilley, R; Yáñez, L	1
Nordmann, P; Ortiz de la Rosa, JM; Poirel, L	1
Ann Justo, J; Bookstaver, PB; Elizabeth Davis, S; Foster, R; Gould, A; Ham, J; Hucks, J; Nicolau, DP	1
Boulanger, B; Cizeau, F; Decousser, JW; Ducellier, D; Fourreau, F; Mercier-Darty, M; Mongardon, N; Podglajen, I; Potron, A; Royer, G	1
Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, P; Galán-Sánchez, F; González-Bello, C; Lence, E; Martínez-Guitián, M; Oliver, A; Rodríguez-Iglesias, M; Vázquez-Ucha, JC	1
Anwar, Z; Guy, JR; Lam, BL; Schatz, NJ; Sternau, LL; Winter, TW	1
Bauer, KA; Goff, DA; O'Brien, JM; West, JE	1
Araki, H; Suemaru, K; Takechi, K; Tanaka, A; Tanaka, M; Watanabe, S	1
Hashiguchi, R; Komatsu, M; Matsuyama, S; Moronaga, Y; Nagahara, C; Oshiro, Y; Sameshima, I; Takeyama, H; Tottori, N; Yaita, K; Yamaguchi, Y	1
Goff, DA; Nicolau, DP	1
Chia, JH; Hsu, PC; Lee, MH; Su, TY; Wu, HF; Ye, JJ	1
Akpolat, N; Aydemir, O; Deniz, N; Güler, M; Kizirgil, A	1
Kuti, JL; MacVane, SH; Nicolau, DP	1
Fatemi, O; Najjar, SS; Ruiz, ME; Sperry, BW	1
Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH	1
Bruchmann, S; Cabot, G; Haussler, S; Juan, C; Moyà, B; Mulet, X; Oliver, A; Zamorano, L	1
Kirikae, T; Miyoshi-Akiyama, T; Narahara, K; Ohmagari, N; Shimojima, M; Tada, T; Tanaka, M; Tojo, M	1
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS	1
Mugnai, G; Pesarini, G; Vassanelli, C	1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Potel, G	1
Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X	1
Bhattacharjee, A; Chakravarty, A; Chanda, DD; Maurya, AP; Talukdar, AD	1
Castanheira, M; Farrell, DJ; Jones, RN; Mills, JC	1
Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G	1
Bhardwaj, N; Biswas, D; Kakati, B; Kotwal, A; Thakuria, B	1
Heil, EL; Lowery, AV; Nicolau, DP; Thom, KA	1
Airapetian, N; Ammenouche, N; Dupont, H; Friggeri, A; Levrard, M; Mahjoub, Y; Mammeri, H; Marciniak, S; Tinturier, F; Zogheib, E	1
Cleveland, KO; Gelfand, MS	1
Chahine, EB; Cogan, P; Fete, M; Sucher, AJ	1
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ	1
Bofarull, AM; Cantón, R; García-Castillo, M; Tato, M	1
Gonzales, JP; Heil, EL; Mehrotra, S; Nicolau, DP; Oliver, WD; Robinett, K; Saleeb, P	1
Bradley, JS; Capparelli, EV; Domonoske, C; Reed, MD; Shoji, K; van den Anker, JN	1
Kuti, JL; Nicolau, DP; Nugent, J; Shepard, A; So, W	1
Greenwood-Quaintance, KE; Karau, MJ; Kohner, PC; Patel, R; Schmidt-Malan, SM; Velez Perez, AL	1
Aitken, SL; Bhatti, MM; DePombo, AM; Gettys, SC; Kontoyiannis, DP; Nicolau, DP; Nunez, CA; Tverdek, FP	1
Higuchi, H; Horikoshi, Y; Isogai, M; Ito, K; Shoji, T; Suwa, J	1
Ghazi, IM; Kuti, JL; Nicolau, DP; Quintiliani, R; Shore, E	1
McClain, D; Vickery, SB; Wargo, KA	1
Cies, JJ; Kuti, JL; Monogue, ML; Muhlebach, M; Nicolau, DP; Pettit, RS	1
Ardebili, A; Azimi, L; Bijari, A; Fallah, F; Lari, AR; Lari, ER	1
Chalhoub, H; Denis, O; Deplano, A; Elborn, JS; Kahl, BC; Mustafa, MH; Rodriguez-Villalobos, H; Traore, H; Tulkens, PM; Tunney, MM; Van Bambeke, F; Vanderbist, F; Vergison, A	1
Borgia, G; Gentile, I; Maraolo, AE	1
Algora-Weber, A; de la Calle-Pedrosa, N; Delgado-Iribarren, A; Gabán-Díez, Á; González-Jiménez, AI; Hernández-Tejedor, A; Martín-Vivas, A; Merino-Vega, CD; Ruiz de Luna-González, R; Temprano-Gómez, I	1
Cabot, G; Domínguez, MÁ; Juan, C; López-Causapé, C; Martínez-Martínez, L; Moyà, B; Ocampo-Sosa, AA; Oliver, A; Peña, C; Plesiat, P; Rodríguez, C; Sommer, LM; Tubau, F; Zamorano, L	1
Elphick, HE; Scott, A	1
Castón, JJ; De la Torre, Á; Ruiz-Camps, I; Sorlí, ML; Torre-Cisneros, J; Torres, V	1
Crespo Casal, M; Martinez-Lamas, L; Nodar, A; Perez-Landeiro, A; Perez-Rodríguez, MT; Sousa Dominguez, A	1
Gentry, CA; Ratliff, AR; Williams, RJ	1
Bassetti, M; Castanheira, M; Duncan, LR; Pfaller, MA	1
Diaz-Martinez, LA; Ramirez-Blanco, CE; Ramirez-Rivero, CE; Sosa-Avila, LM	1
Chaudhary, M; Sehgal, R; Shrivastava, SM; Varughese, L	1
Cruz, OL; de Oliveira Penido, N; Inoue, DP; Testa, JR	1
Bassetti, M; Repetto, E	1
Alquezar, A; Castro, P; Codina, C; Delgado, E; Marco, F; Martí, S; Martínez, JA; Mensa, J; Nicolás, JM; Soriano, A; Torres, A; Trilla, A; Vila, J	1
Hauber, HP; Mack, D; Pforte, A; Schulz, M; Schumacher, U; Zabel, P	1
Micek, ST; Neuner, EA; Ritchie, DJ	1
Deal, EN; Micek, ST; Reichley, RM; Ritchie, DJ	1
Bou, G; Torres, E; Villanueva, R	1
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T	1
Eagye, KJ; Kuti, JL; Nicasio, AM; Nicolau, DP; Palter, M; Pepe, J; Shore, E	1
Ge, Y; Livermore, DM; Mushtaq, S; Warner, M	1
Ge, J; Giske, CG; Nordmann, P	1
Ariza, J; Dominguez, MA; Juan, C; Moya, B; Oliver, A; Peña, C; Pujol, M; Suarez, C; Tubau, F	1
Fraser, A; Leibovici, L; Paul, M; Yahav, D	1
Boonkerd, N; Niumsup, PR; Pibalpakdi, P; Tiloklurs, M	1
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L	1
Abbanat, D; Bush, K; Fernandez, J; Flamm, RK; Hilliard, JJ; Melton, JL; Santoro, CM; Zhang, W	1
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A	1
Ge, Y; Juan, C; Oliver, A; Pérez, JL; Zamorano, L	1
Cantón, R; Fernández-Olmos, A; Ge, Y; Juan, C; Oliver, A; Zamorano, L	1
Bulik, CC; Crandon, JL; Kuti, JL; Nicolau, DP	1
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS	1
Ge, Y; Juan, C; Moya, B; Oliver, A; Pérez, JL; Zamorano, L	1
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC	1
Cerceo, E; Lichaa, H; Rachoin, JS; Rajput, V; Surkis, W	1
Ge, Y; Macià, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL; Riera, E	1
Chong, Y; Ito, Y; Kamimura, T; Yakushiji, H	1
Aoki, Y; Fukuoka, M; Magarifuchi, H; Nagasawa, Z; Nagata, M; Urakami, T	1
Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D	1
Willcox, MD	1
Davis, GA; Feola, DJ; Hayes, D; Kuhn, RJ; Murphy, BS	1
Bosso, JA; Church, EC; Mauldin, PD	1
Mercuri, LG; Psutka, D	1
Campo Esquisabel, AB; Campo-Sosa, AO; Martínez-Martínez, L; Rodríguez, C; Rodríguez, MC	1
Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J	1
Akhabue, E; Bilker, WB; Lautenbach, E; Synnestvedt, M; Weiner, MG	1
Ozbilim, G; Ozbudak, IH; Ozbudak, O; Ozdem, S; Sahin, N; Turkay, C; Turkay, M	1
Bahniuk, N; Bonomo, RA; Brown, D; Bulitta, JB; Defiglio, H; Drawz, SM; Drusano, GL; Fikes, S; Kulawy, R; Louie, A; Vanscoy, B	1
Bulik, CC; Keel, RA; Nicolau, DP; Sutherland, CA; Tessier, PR	1
Jardine, D; McNally, A; Pithie, A	1
Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L	1
Faoagali, J; Gallagher, JE; George, N; Gidding, HF; Ginn, AN; Iredell, JR; Lipman, J; O'Driscoll, JS; O'Toole, BI; Partridge, SR; Perri, RA; Wiklendt, AM	1
Amador, G; Asehnoune, K; Boutoille, D; Broquet, A; Caillon, J; Desessard, C; Jacqueline, C; Le Mabecque, V; Potel, G; Roquilly, A	1
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT	1
Andes, DR; Craig, WA	1
Chanteux, H; Mingeot-Leclercq, MP; Servais, H; Tulkens, PM; Viaene, E	1
Bonnet, R; Chanal, C; De Champs, C; Nordmann, P; Poirel, L; Sirot, D; Sirot, J	1
Abou-Madi, N; Kern, TJ	1
Matsuda, H; Miwa, H; Miyazaki, S; Tsuji, M	1
Drusano, GL; Lomaestro, BM; Louie, A; Tam, VH	1
Oishi, K	1
Adriensen, B; Husson, MO; Loiez, C; Massoni-Cristante, S	1
Kuwahara, S; Miwa, H; Shimada, J; Takema, M; Tsuji, M	1
Ceran, N; Erdem, I; Kucukercan, M	1
Keene, WE; Markum, AC; Samadpour, M	1
Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K	1
Babalola, CP; Nicolau, DP; Nightingale, CH	1
Bugnon, D; Caillon, J; Gras-Le Guen, C; Jacqueline, C; Kergueris, MF; Navas, D; Potel, G	1
Cefalo, G; Massimino, M; Mazza, E; Scaramuzza, D; Spreafico, F	1
Betsunoh, H; Hamasuna, R; Nagano, M; Osada, Y; Sueyoshi, T; Takehara, T; Tsukino, H; Yakushiji, K	1
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Mouktaroudi, M; Perrea, D	1
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM	1
Ho, SW; Hsueh, PR; Teng, LJ; Tseng, SP	1
Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A	1
Araki-Sasaki, K; Asari, S; Matsumoto, K; Mutoh, K; Nishi, I; Takatsuka, H; Tanihara, H; Yonemura, N	1
Rumbaugh, JA; Sinha, G; Spalding, C; Speedie, A; Venkatesan, A	1
Dubovik, LG; Kolbatova, ES; Polikarpova, SV; Postnikov, SS; Semykin, SIu	1
Koulenti, D; Rello, J	1
Li, C; Nicolau, DP; Nightingale, CH; Ong, CT; Tessier, PR	1
Bulitta, J; Kirkpatrick, CM; Lipman, J; Roos, JF	1
Konkoly-Thege, M; Kuti, JL; Ludwig, E; Nicolau, DP	1
Hatano, K; Ikeda, F; Nakai, T; Takeda, S; Wakai, Y	1
Bertrand, X; Blanc, K; Hocquet, D; Monnet, DL; Muller, A; Plésiat, P; Talon, D	1
Decorby, M; Hoban, DJ; Karlowsky, JA; Nichol, K; Walkty, A; Zhanel, GG	1
Fujimura, N; Kurokawa, K; Uema, K; Yuasa, K	1
Belohradsky, BH; Bruch, K; Geiss, D; Kafetzis, D; Marget, W; Peters, G	1
Fujita, K; Sakata, H; Yoshioka, H	1
Burdon, DW; Keighley, MR; Morris, DL; Young, D	1
Barza, M; Murphy, TF	1
Cherubin, CE; Corrado, ML; Landesman, SH	1
Aguirre, M; Alés, JM; Torres, A; Vega, J	1
Caparosa, R; Haverkos, HW; Kamerer, D; Yu, VL	1
Johnson, CE; Pennington, JE; Platt, R	1
Giger, DK; Goering, RV; Penn, RG; Preheim, LC; Sanders, CC	1
Eaglstein, NF; Hernandez, AD; Marley, NF; Marley, WM; Rosenberg, EW	1
Nishino, T; Saito, M; Shibata, K; Tanino, T	1
Fitzpatrick, SB; Rosenstein, BJ	1
Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Kern, JW; Yellin, AE	1
Gimbrère, JS; Muytjens, HL; van Dalen, R	1
Eron, LJ; Goldenberg, RI; Hixon, DL; Park, CH; Poretz, DM	1
Modai, J; Nevot, P; Philippon, A; Vittecoq, D	1
Goodwin, CS	1
Canton, P; Dureux, JB; Gérard, A; Roche, G; Weber, M	1
Borderon, JC; Boulard, P; Despert, F; Grenier, B; Laugier, J; Santini, JJ	1
Gérard, A; Paris, J; Paris, JC	1
Slack, MP	1
Neu, HC; Prince, AS	1
Crawford, ED; Plimpton, HW	1
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G	1
Guggenbichler, JP	1
Stille, W	1
Baumgärtner, M	1
Meulemans, A; Modai, J; Vittecoq, D	1
Assael, BM; Brienza, A; Crossignani, RM; Giunta, A; Granata, F; Lodi, G; Padoan, R; Passarella, E; Vallaperta, PA; Xerri, L	1
Davies, BI; Maesen, FP; van Noord, JA	1
Bint, AJ; Constable, FL; Constable, J; Patton, KR	1
Abbas, AM; Cantor, AM; Haste, AR; Jones, RB; Newby, D; Rigby, CC; Taylor, MC	1
Butzler, JP; Clumeck, N; Dab, I; Gordts, B; Jaspar, N; Van Laethem, Y	1
Fliegelman, RM; Karakusis, PH; Levin, S; Pottage, JC; Trenholme, GM	1
Dutoy, JP; Wauters, G	1
Alfredson, H; Ericsson, A; Malmborg, AS; Strandvik, B	1
Blumer, JL; Kercsmar, CM; Murdell, D; Myers, CM; Reed, MD; Stern, RC	1
Christensen, HO; Høiby, N; Koch, C; Møller, AF; Møller, S; Permin, H	1
Dodge, J; Goodchild, M; Ingram, P; Zamiri, I	1
Fleming, PC; Gold, R; Isles, A; Jin, E; Levison, H	1
Connor, PJ; David, TJ; Phillips, BM	1
Assael, BM; Boccazzi, A; Caccamo, ML; Giunta, A; Marini, A; Padoan, R; Rusconi, F; Sereni, F	1
Kaar, ML; Lautala, P; Vare, M; Vuorinen, O	1
Cullen, RT; Govan, J; Ingram, TM; McCrae, WM; Raeburn, JA	1
Nakayama, I	1
Ingham, HR; Selkon, JB; Snow, MH; Wardle, JK	1
Foord, RD	1
Cox, CE	1
Childs, SJ; Douthit, MB; Gentry, LO; Madsen, PO	1
Kawamura, N	1
Allan, SG; Glover, SC; Hadley, KM; Han, K; Ingram, PM; Murdoch, JM; Reid, TM; Smith, CC	1
Butzler, JP; Clumeck, N; Gordts, B; Jaspar, N; Van Laethem, Y	1
Choudhary, BP; Elliott, TS; Ispahani, P	1
Assael, BM; Florioli, A; Rusconi, F; Zaffaroni, G	1
Kawamura, N; Kishi, Y; Kumamoto, Y; Miyamoto, S; Niijima, T; Nishimura, Y; Ohkoshi, M; Okada, K; Saito, I; Yuge, J	1
Bauernfeind, A; Blaser, J; Lüthy, R; Vogt, M	1
El-Sadr, W; Maslow, MJ; Pollock, AA; Press, RA; Rahal, JJ; Richmond, AS; Rosenberg, A; Silverman, D; Simberkoff, MS	1
Gabler-Sandberger, E	1
Eykyn, S; King, A; Phillips, I; Shannon, K	1
Heilesen, AM; Høiby, N; Koch, C; Permin, H	1
Neu, HC; Scully, BE	1
Cabezudo, I; Guenthner, SH; Selden, RF; Thompson, RL; Wenzel, RP	1
Drake, TA; Hackbarth, CJ; Rusnak, MG; Sande, MA	1
Cattin, J; Dupont, MJ; Jouvenot, M; Michel-Briand, Y	1
Harper, PB	1
Gold, R; Isles, AF; Leeder, JS; MacLeod, SM; Spino, M; Tesoro, AM	1
Nishimura, T; Takashima, T	1
Ohkoshi, M	1
Modde, H	1
Yu, VL	1
Carson, M; McDonald, M; Miles, H	1
Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS	1
Hajsig, D; Skalova, R; Smerdel, S	1
Endo, K; Imamura, K; Kumasaka, Y; Masaki, N; Matsuhashi, A; Nakahata, H; Narita, S; Sasaki, K; Takebe, K; Tamura, T	1
Kemp, R	1
McGregor, DN; Price, KE	1
Flensborg, EW; Høiby, N; Szaff, M	1
Futaki, T; Oda, M	1
Bergogne-Berezin, E; Berthelot, G; Even, P; Kafe, H; Safran, D	1
McGinness, L; Sherwood, CF; Vanore, JV	1
Bouvet, E; Regnier, B; Schlemmer, B; Vachon, F; Witchitz, J; Witchitz, S	1
Baba, S; Boku, S; Chikuie, D; Fujii, K; Goto, K; Harada, Y; Hirata, K; Inafuku, S; Maruo, T; Maruyama, H; Miyake, H; Miyamae, M; Miyano, K; Murata, K; Nakai, Y; Nomura, T; Ogawa, A; Ohashi, Y; Ohta, F; Saito, N; Sakai, M; Sasaki, T; Sato, K; Sugiyama, M; Takimoto, I; Ueda, T; Yajin, K; Yamashita, K; Yonei, K; Yoshizumi, T	1
Rozhavin, MA	1
Dreznik, Z; Mark, Z; Rubinstein, E	1
Balmayer, B; Bertrand, A; Despaux, E; Janbon, F; Jonquet, O; Lepeu, G; Santoni, A	1
Jensen, K; Koch, C; Møller, NE; Vesterhauge, S	1
Abergel, P; Reignier, B; Vachon, F; Witchitz, J; Witchitz, S; Wolff, M	1
Kasanen, A; Nikoskelainen, J; Saarimaa, H; Toivanen, P	1
Hirooka, J; Hori, M; Kitani, N; Kurosu, Y; Nishiyama, H; Sugita, M; Takahashi, T; Toyonaga, Y; Yokoi, S	1
Hoshina, H; Ichihashi, H; Yanagisawa, K	1
Iwai, N; Mizoguchi, F; Nakamura, H; Sasaki, A; Taneda, Y	1
Hiromatsu, K; Nishimura, T; Tabuki, K; Takashima, T	1
Cho, N; Deguchi, K; Doko, F; Domon, H; Endo, K; Fugono, T; Fukae, T; Fukunaga, K; Goto, T; Hagiwara, K; Hanaoka, S; Hasegawa, Y; Hayasaki, M; Hayashi, S; Hirabayashi, K; Hogaki, M; Ichinohe, K; Ihara, Y; Iwasa, S; Kaku, R; Kodama, M; Kohlita, Y; Kubota, K; Kunii, K; Kusaba, N; Kutsuzawa, T; Matsuda, S; Mizuta, E; Motomura, R; Muronosono, E; Nakamura, H; Ninomiya, K; Noda, K; Ohbayashi, F; Osada, H; Seiga, K; Shiojima, Y; Sumiyoshi, Y; Tabei, T; Takase, Z; Tsuruta, S; Wagatsuma, T; Yabuki, A; Yamabe, T; Yamada, F; Yamada, Y; Yorozu, Y	1
Preheim, LC; Sanders, WE	1
Green, RA	1
Haruta, T; Kobayashi, Y	1
Davies, AJ	1
Donta, ST; Villar, LA	1
Ortel, S	1
Aoyama, R; Izumi, Y; Kakizaki, Y; Kuronuma, T; Nomura, Y; Ohnishi, A	1
Fujii, R; Hashimoto, G; Hashira, S; Hiraiwa, M; Koike, Y; Meguro, H; Ozawa, S; Takahashi, A	1
Chikaoka, H; Hirama, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Tazoe, K	1
Akita, H; Hattori, H; Hotta, M; Ichihashi, Y; Iwasaki, Y; Iwata, S; Iwata, T; Jozaki, K; Kanemitsu, T; Nanri, S; Osano, M; Sunagawa, K; Yamashita, N	1
Hachimori, K; Minamitani, M; Suzuki, M	1
Fuke, H; Okamoto, K; Ozaki, H; Shino, K; Watanabe, K	1
Weinstein, AJ	1
Makishima, K; Masuda, T; Nakashima, T; So, N; Watanabe, H	1
Deguchi, K; Fujimaki, Y; Kawamura, S; Sugita, R	1
Matsuoka, H; Mizukoshi, F; Mizukoshi, O; Nakamura, A; Nishimura, T; Okawa, K; Saito, A; Saito, H; Sato, F; Tachibana, M; Takenouchi, S; Yanohara, K	1
Kannae, S; Makishima, K; Murata, Y; Nakashima, T; Toriya, Y; Watanabe, H	1
Kojima, S; Komatsuzaki, A; Osafune, H; Satake, K; Unoki, S	1
Fukuda, K; Furuta, S; Iida, F; Ogawa, K; Ohhori, Y; Ohyama, M	1
Ferguson, M; Sleigh, JD; Wright, PA	1
Hajiro, A; Hamagaki, H; Henmi, K; Hikasa, Y; Kikuchi, S; Kobayashi, M; Maki, Y; Masuda, K; Matsukawa, Y; Mukaihara, S; Nakajima, K; Nio, Y; Sugimoto, S; Takenada, M; Tanimura, H; Usui, H; Yasumoto, H	1
Dusehu, E; Veyssier, P	1
Rosenkranz, A	1
Shannon, KP	1
Cappelletty, DM; Kang, SL; Palmer, SM; Rybak, MJ	1
Hikida, M; Kawashima, K; Mitsuhashi, S; Nishiki, K; Yamazaki, Y; Yoshida, M	1
Anderhuber, W; Köle, W; Walch, C	1
Munakata, K; Satoh, M; Takeuchi, H; Yoshida, O	3
Carbon, C; Fantin, B; Farinotti, R; Thabaut, A	1
Fung-Tomc, J; Gradelski, E; Huczko, E; Kessler, RE	1
Klastersky, J	1
Hayashi, R; Iizawa, Y; Imada, A; Iwahi, T; Okonogi, K; Yamazaki, T	1
Hasegawa, T; Hirano, M; Imae, K; Imura, S; Kamachi, H; Kamei, H; Okita, T	1
Byrne, S; Connor, P; David, TJ; Dodd, M; Doughty, I; Jenney, M; Maddison, J; Webb, AK	1
Brouqui, P; Drancourt, M; Raoult, D; Rousseau, MC; Stein, A	1
Klepser, ME; Nicolau, DP; Nightingale, CH; Patel, KB; Quintiliani, R	1
Ishibashi, K; Ogihara, M; Shigeta, S; Shiraiwa, Y; Yamaguchi, O	1
Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K	1
Geletko, SM; Melbourne, KM; Mikolich, DJ	1
Lee, CP; Lim, AS; Tan, DT	1
Calegari, L; Carmona, C; Gezuele, E; Torres, E	1
Banas, B; Combe, C; Manns, MP; Schlöndorff, D; Zoller, WG	1
Arenas, JI; Arriola, JA; Gil, I; Montalvo, II	1
Beauchamp, D; Bergeron, MG; Morin, NJ; Simard, M; Turcotte, A	1
Okonogi, K; Tsuchimori, N; Yamazaki, T	1
Adachi, Y; Fuse, A; Hashizume, T; Kato, E; Nagano, R; Nakagawa, S; Ohtake, N; Okamoto, O; Shibata, K	1
Alfaro, DV; Barton, CP; Beverly, DT; Brucker, AJ; Hudson, SJ; Kasowski, EJ; King, LP; Lopez, JD	1
Helm, CJ; Holland, GN; Maloney, RK; Mondino, BJ; Webster, RG	1
Farca, AM; Maffei, F; Piromalli, G; Re, G	1
Daschner, FD; Engels, I; Lemmen, SW	1
D'Amico, DT; Ng, EW	1
Battles, A; Liu, QF; Liu, W; Louie, A; Miller, DA; Miller, MH; Sucke, AC	1
Ghani, M; Soothill, JS	1
Donzis, PB	1
Akbal, H; Coşkunkan, F; Ozturk, R; Saribas, S; Tansel, O; Vahaboglu, H	1
Bailly, P; Mulin, B; Rouget, C; Talon, D; Thouverez, M; Viel, JF	1
Breysem, L; De Boeck, K	1
Belli, DC; Dayer Pastore, F; Dudez, TS; Rochat, T; Schlegel-Haueter, SE; Suter, S	1
Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M; Sato, K	1
Barberán, J; Campos, A; García, MC; Khorrami, S	1
Arrouet-Lagande, C; Ategbo, S; Deschildre, A; Druon, D; Husson, MO; Launay, V; Loeuille, GA; Sardet, A; Turck, D; Vic, P	1
Akbal, H; Ozturk, R; Saribaş, S; Vahaboglu, H; Yucel, A	1
Ategbo, S; Canis, F; Husson, MO; Trivier, D; Turck, D; Vic, P	1
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C	1
Biedenbach, DJ; Doern, GV; Jones, RN; Marshall, SA; Pfaller, MA	1
Bhutta, ZA; Ladhani, S	1
Blondeau, JM; Borsos, S; Misfeldt, C; Suter, ME	1
Berger, D; Heinemann, M; Möricke, A; Seidelmann, M; Trautmann, M; Zick, R	1
Blackshear, P; Branch, S; Chernoff, N; Hall, L	1
Ikeda, N; Matsuyama, N; Watanabe, K	1
Avisar, R; Gaton, D; Kremer, I; Robinson, A; Savir, H; Yassur, Y	1
Chen, SC; Fung, CP; Lee, N; Lee, SC; Liu, PY; See, LC; Shieh, WB; Wang, TC	1
Bowler, SD; McCormack, JG; Wolter, JM	1
Asumang, A; Dryden, M; Goldsmith, AL	1
Endo, K; Itabashi, S; Kano, M; Sasaki, H	1
Lipener, C; Ribeiro, AL	1
Po, AL; Scott, EM; Tariq, VN; Wu, YL	1
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K	1
Banevicius, MA; Nicolau, DP; Nightingale, CH; Quintiliani, R	1
Banevicius, MA; Bui, KQ; Nicolau, DP; Nightingale, CH; Quintiliani, R	1
Gagnon, L; Huletsky, A; Langaee, TY	1
Burgos, A; Campillos, P; Gonzalo, N; López-Lozano, JM; Monnet, DL; Saez, M; Yagüe, A	1
D'Errico, G; Esposito, S; Ianniello, F; Noviello, S	1
Aebischer, CC; Bettinelli, A; Bianchetti, MG; Truttmann, AC; von Vigier, RO; Wermuth, B; Zindler-Schmocker, K	1
Buyan-Dent, L; Dixit, S; Kurle, P; Sheth, RD	1
Collins, J; Disney, A; Harris, DC; Ibels, LS; Murphy, BF; Rigby, R; Saltissi, D; Suranyi, M	1
Bucaneve, G; Del Favero, A; Dionisi, MS; Furno, P; Menichetti, F	1
Kawano, C; Kirikae, T; Muroi, K; Ozawa, K; Yozhizawa, M	1
Akiyama, M; Matsumoto, K; Oishi, K; Pollack, M; Tao, M	1
Fialkowski, JP; Lautzenhiser, SJ; Moore, KW; Rosin, E; Trepanier, LA	1
Bébéar, JP; Darrouzet, V; Duclos, JY; Guyot, M; Martel, J	1
Felts, AG; Grainger, DW; Slunt, JB	1
Bagge, N; Ciofu, O; Høiby, N; Skovgaard, LT	1
Feldman, DP; Picerno, NA; Porubsky, ES	1
Bélaz, N; Bille, J; Decosterd, LA; Pilet, M; Rappaz, I; Roulet, M	1
Iizawa, Y; Ishikawa, T; Miyake, A; Okonogi, K	1
Iizawa, Y; Ishikawa, T; Kamiyama, K; Matsunaga, N; Miyake, A; Okonogi, K; Tawada, H	1
Comes, G; Harms, K; Paul, K; Posselt, HG; Ratjen, F; Wagner, TO	1
Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K	1
Amicosante, G; Lombardi, G; Luzzaro, F; Mantengoli, E; Orlandi, V; Orsatti, A; Perilli, M; Rossolini, GM; Toniolo, A	1
Baghurst, PA; Colebatch, KA; Coulthard, KP; Hansman, D; Holmes, M; Jarvinen, A; Kennedy, D; Linke, RJ; Martin, A; Martin, AJ; Master, V; Onishko, CR; Parsons, DW; Roberts, GW; Roberts, ME	1
Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C	1
Chow, KM; Leung, CB; Li, PK; Lui, SF; Szeto, CC; Wang, AY; Wong, TY; Wu, AK	1
Mayer, I; Nagy, E	1
Cassetta, MI; Conti, S; Fallani, S; Novelli, A	1
Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH	1
Smyth, A; Walters, S	1
Cavallo, JD; Fabre, R; Fourticq-Esqueöute, A; Leblanc, F	1
Wareham, DW	1
Leblanc, PE; Leotard, S; Nordmann, P; Poirel, L	1
Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K	1
Fennewald, M; Girlich, D; Leelaporn, A; Naas, T; Nordmann, P; Poirel, L	1
Ambrose, PG; Garvey, MJ; Jones, RN; Owens, RC	1
Burns, JL	1
Beach, ML; Biedenbach, DJ; Jones, RN; Kirby, JT; Pfaller, MA	1
Stratford, BC	1
Adam, D	1
Chico Rizzo, E	1
Kondo, M; Tsuchiya, K	1
Balcke, P; Graninger, W; Kopsa, H; Pils, P; Schimatzek, A; Schmidt, P; Zazgornik, J	1
Ahronheim, GA	1
Hopefl, AW	1
Naumann, P; Rosin, H	2
Fowst, G; Nessi, R	1
Hitzenberger, G	1
Hutschenreiter, G; Klippel, KF	1
Kondo, M; Nagatomo, H; Tsuchiya, K	1
Levine, LR; McCain, E	1
Ellis, LF; Herron, DK; Preston, DA; Schlegel, RA; Simmons, LK	1
Donovan, TL; Gordon, RO; Nagel, DA	1
Asmal, AC; Bima, B; Leary, WP; Lockett, CJ	1
Imai, K; Kamiya, T; Koie, K; Ono, R; Yoshikawa, H	1
Giamarellou, H	1
Bailey, EM; Lamp, KC; McGrath, BJ; Rybak, MJ	1
Pechère, JC; Vladoianu, IR	1
Tabuki, K	1
Abe, S	1
Pizzo, P	1
Baltch, AL; Franke, M; Michelsen, P; Ritz, WJ; Singh, J; Smith, RP; Valdes, JM; Williams, S	1
Atsumi, K; Inouye, S; Iwamatsu, K; Kondo, S; Ogino, H; Sakagami, K; Shibahara, S; Tsuruoka, T; Yoshida, T	1
Jiang, XF	1
Inouye, S; Iwamatsu, K; Katano, K; Kondo, S; Nakabayashi, S; Ogino, H; Tsuruoka, T; Yoshida, T	1
Inouye, S; Iwamatsu, K; Katano, K; Kondo, S; Nakabayashi, S; Ogino, H; Shibahara, S; Tsuruoka, T; Yoshida, T	1
Arai, S; Hayashi, S; Kobayashi, S	1
Yu, GH; Yuan, JP; Zhong, NS	1
Ukhin, AV	1
Inouye, S; Kondo, S; Kudo, T; Murai, Y; Okonogi, T; Shibahara, S; Yoshida, T	1
Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME	1
DeOrio, FJ; Dougherty, TJ; Fung-Tomc, J; Kessler, RE; Simich-Jacobson, V	1
Asahi, Y; Hashizume, T; Matsuda, K; Nakagawa, S; Ohtake, N; Sanada, M; Tanaka, N; Ushijima, R	1
Benecke, JE	1
Abruzzo, GK; Bland, JA; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Hadley, SK; Pelak, BA; Weissberger, BA	1
Donowitz, GR	1
Ingerman, MJ; Levison, ME; Pitsakis, PG; Rosenberg, AF	1
Borner, K; Brückner, O; Collmann, H; Hoffmann, HG; Trautmann, M	1
Burdeska, A; Costa, E; Follath, F; Frei, R; Meyer, J; Thommen, A	1
Blumer, JL; Myers, CM; Reed, MD; Stern, RC; Yamashita, TS	1
Bustamante, CI; Johnson, DE; Wade, JC	1
Nonomura, M; Yoshida, O	1
Fu, KP; Gregory, FJ; Hetzel, N; Hung, PP	2
Badenoch, PR; Coster, DJ; McDonald, PJ	1
Fu, KP; Gregory, JF; Hung, PP; Vince, T	1
Badenoch, PR; Coster, DJ; Hay, GJ; McDonald, PJ	1
Buxton, TB; Rissing, JP; Shockley, RK; Yannis, RA	1
Guenthner, SH; Norris, SM; Wenzel, RP	1
Bryskier, A; Chantot, JF	1
Chiang, ST; Fu, KP; Gregory, FJ; Hung, PP; McCloud, S; Vince, T	1
Young, LS	1
Bodey, GP; Horikoshi, N; Rodriguez, V; Valdivieso, M	1
Schwab, W	1
Plotkin, SA	1
Neff, G; Plaue, R	1
Guenther, M; Mössner, G	1
Lang, GR; Levin, S	1
Boxerbaum, B	1
Eudy, WW	1
Ellorhaoui, M; Tauchnitz, C	1
Haschek, H; Porpaczy, P; Schmidt, W	1
Minakawa, M; Miyoshi, K; Seika, K; Sugiyama, Y; Yamaji, K	1
Finsterbush, A; Weinberg, H	1
Hodson, AH; Holloway, WJ	1
Marr, JJ	1
Lüthy, R; Siegenthaler, G; Siegenthaler, W; Vetter, H	1
Bullock, WE	1
Kanda, M; Maekawa, N; Nakanishi, M; Tsukuma, S; Yamashita, M	1
Geddes, AM; Munro, JF; Murdoch, JM	1

Reviews

52 review(s) available for cephalosporin c and Infections, Pseudomonas

Article	Year
Ceftolozane-tazobactam: When, how and why using it? Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34 Suppl 1 Topics: Anti-Bacterial Agents; Cephalosporins; Colistin; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Ceftolozane-tazobactam in nosocomial pneumonia. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 1 Topics: Adult; Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans; Pseudomonas Infections; Tazobactam	2022
Treatment of carbapenem-resistant Expert review of anti-infective therapy, 2022, Volume: 20, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2022
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa? Current opinion in infectious diseases, 2023, 12-01, Volume: 36, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Seizures	2023
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam; Urinary Tract Infections	2020
Approach to the Treatment of Patients with Serious Multidrug-Resistant Pseudomonas aeruginosa Infections. Pharmacotherapy, 2020, Volume: 40, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. International journal of antimicrobial agents, 2020, Volume: 56, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Drug Monitoring; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam; Young Adult	2020
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature. Infection, 2021, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Phage Therapy; Pseudomonas aeruginosa; Pseudomonas Infections	2020
A Critical Evaluation of Newer β-Lactam Antibiotics for Treatment of The Annals of pharmacotherapy, 2021, Volume: 55, Issue:8 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Real-world use of ceftolozane/tazobactam: a systematic literature review. Antimicrobial resistance and infection control, 2021, 04-08, Volume: 10, Issue:1 Topics: Cephalosporins; Comorbidity; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections	2021
New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam. Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2021, 06-23, Volume: 6 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2021
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections. Current opinion in infectious diseases, 2021, 12-01, Volume: 34, Issue:6 Topics: Anti-Bacterial Agents; Cephalosporins; Critical Illness; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Critical Illness; Disease Management; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Intensive Care Units; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Tazobactam; Treatment Outcome	2017
Ceftolozane/tazobactam: place in therapy. Expert review of anti-infective therapy, 2018, Volume: 16, Issue:4 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Off-Label Use; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2018
Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis. Paediatric respiratory reviews, 2018, Volume: 27 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2018
Risk factors for hospitalized patients with resistant or multidrug-resistant Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin	2018
The ideal patient profile for new beta-lactam/beta-lactamase inhibitors. Current opinion in infectious diseases, 2018, Volume: 31, Issue:6 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Liver abscess caused by multidrug-resistant Pseudomonas aeruginosa treated with colistin; a case report and review of the literature. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:12 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cholangitis; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Kidney; Liver Abscess, Pyogenic; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections	2013
Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination. The Annals of pharmacotherapy, 2015, Volume: 49, Issue:9 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Humans; Intraabdominal Infections; Mice; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2015
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2016, 12-01, Volume: 12 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2016
[Diagnostic and therapeutic management of Gram-negative infections]. Le infezioni in medicina, 2008, Volume: 16 Suppl2 Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Management; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections	2008
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. The Cochrane database of systematic reviews, 2010, Nov-10, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins	2010
Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clinical & experimental optometry, 2011, Volume: 94, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gentamicins; Humans; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus	2011
Eradication of Pseudomonas aeruginosa in an adult patient with cystic fibrosis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Feb-15, Volume: 68, Issue:4 Topics: Adult; Anti-Infective Agents; Cefepime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2011
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins. Pediatric pulmonology, 2013, Volume: 48, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin	2013
[Pseudomonas aeruginosa infection]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Biofilms; Carbapenems; Cephalosporins; Fimbriae, Bacterial; Flagella; Humans; Immunocompromised Host; Multidrug Resistance-Associated Proteins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Trans-Activators; Urinary Tract Infections	2003
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:9 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2005
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12 Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin	2006
Antipseudomonal beta-lactams. The Journal of antimicrobial chemotherapy, 1981, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1981
[Drug resistance of bacteria--the current status and future prospect. 5. Pseudomonas aeruginosa]. Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:3 Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Humans; Infant; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors	1984
[Antipseudomonal activities of new cephem antibiotics]. Hinyokika kiyo. Acta urologica Japonica, 1984, Volume: 30, Issue:4 Topics: Cephalosporins; Drug Resistance, Microbial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship; Urinary Tract Infections	1984
[Modern aspects of the treatment of Pseudomonas aeruginosa infection]. Antibiotiki, 1980, Volume: 25, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Humans; Immunotherapy; Penicillin Resistance; Penicillins; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence	1980
[Prospects of antibiotic treatment in pediatric field]. Nihon rinsho. Japanese journal of clinical medicine, 1981, Volume: 39, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Pneumonia; Pseudomonas Infections; Whooping Cough	1981
Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis. Ophthalmology, 1997, Volume: 104, Issue:5 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoglycosides; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Scleritis; Visual Acuity	1997
[Pseudomonas aeruginosa pneumonia]. Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1 Topics: Cefoperazone; Cephalosporins; Diagnosis, Differential; Humans; Immunocompromised Host; Penicillins; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections	1999
Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Middle Aged; Mortality; Neutropenia; Odds Ratio; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2000
Cephalosporins: a pharmacological update. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6 Suppl 3 Topics: Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2000
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2002
Empiric therapy of febrile granulocytopenic patients. American journal of hospital pharmacy, 1979, Volume: 36, Issue:2 Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin	1979
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence. The Journal of international medical research, 1979, Volume: 7, Issue:3 Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Lincomycin; Mycoses; Nalidixic Acid; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Staphylococcal Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim; Urinary Tract Infections; Vancomycin	1979
Malignant otitis externa: the therapeutic evolution of a lethal infection. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Fluoroquinolones; Humans; Otitis Externa; Pseudomonas Infections	1992
Use of third-generation cephalosporins. Pseudomonas. Hospital practice (Office ed.), 1991, Volume: 26 Suppl 4 Topics: Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	1991
Third generation cephalosporins. Infectious disease clinics of North America, 1989, Volume: 3, Issue:3 Topics: Bacteria; Cephalosporins; Cross Infection; Humans; Meningitis; Pseudomonas Infections; Structure-Activity Relationship	1989
Cephalosporin therapeutics in cystic fibrosis. The Journal of pediatrics, 1986, Volume: 108, Issue:5 Pt 2 Topics: Cefsulodin; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Humans; Kinetics; Lung Diseases; Pseudomonas Infections; Structure-Activity Relationship	1986
Monotherapy for empiric treatment of fever in granulocytopenic cancer patients. The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Bactericidal Activity; Cephalosporins; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Humans; Neoplasms; Penicillins; Pseudomonas Infections; Sepsis; Thienamycins	1986
[Chemotherapy of urinary tract infections caused by Pseudomonas]. Nihon rinsho. Japanese journal of clinical medicine, 1986, Volume: 44, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Penicillins; Pseudomonas; Pseudomonas Infections; Urinary Tract Infections	1986
[Sulfonamide and antibiotic usage in otolaryngology (author's transl)]. HNO, 1974, Volume: 22, Issue:6 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Chloramphenicol; Erythromycin; Escherichia coli Infections; Gentamicins; Humans; Infant; Klebsiella Infections; Microbial Sensitivity Tests; Neomycin; Otorhinolaryngologic Diseases; Penicillins; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Streptococcal Infections; Streptomycin; Sulfonamides; Tetracycline; Tracheoesophageal Fistula	1974
Diagnosis and treatment of urinary tract infections. The Medical clinics of North America, 1971, Volume: 55, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chloramphenicol; Culture Media; Cycloserine; Cystitis; Erythromycin; Escherichia coli Infections; Gentamicins; Hemagglutination Tests; Humans; Kanamycin; Methenamine; Methods; Nalidixic Acid; Nitrofurantoin; Penicillins; Polymyxins; Pseudomonas Infections; Pyelonephritis; Rifampin; Streptomycin; Sulfonamides; Tetracycline; Trimethoprim; Urinary Tract Infections	1971
[Clinical picture and antibiotic therapy of bacterial septicemias in internal medicine]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1971, Volume: 77 Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Endocarditis, Bacterial; Enterobacter; Escherichia coli Infections; Germany, West; Humans; Klebsiella Infections; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Staphylococcal Infections	1971

Trials

39 trial(s) available for cephalosporin c and Infections, Pseudomonas

Article	Year
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia-proposal for an umbrella randomized controlled trial. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:7 Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections	2023
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP). International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; DNA, Bacterial; Double-Blind Method; Drug Resistance, Bacterial; Healthcare-Associated Pneumonia; Humans; Meropenem; Multicenter Studies as Topic; Multilocus Sequence Typing; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Tazobactam; Treatment Outcome	2021
Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study. Annals of clinical microbiology and antimicrobials, 2017, Jul-24, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Female; Hospitals; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome	2017
Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Patient Safety; Penicillanic Acid; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Tazobactam	2016
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. Current clinical pharmacology, 2008, Volume: 3, Issue:2 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Treatment Outcome	2008
Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients. International journal of medical sciences, 2008, Volume: 5, Issue:6 Topics: Administration, Inhalation; Adult; Aminoglycosides; C-Reactive Protein; Cell Count; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Fucose; Galactose; Gene Expression; Humans; Immunoglobulin Isotypes; Leukocytes, Mononuclear; Liver Function Tests; Male; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Treatment Outcome; Tumor Necrosis Factor-alpha	2008
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Clinical therapeutics, 2009, Volume: 31, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Citrobacter freundii; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome	2009
Prospective randomized trial of single dose cefuroxime against mezlocillin in elective gastric surgery. The Journal of hospital infection, 1984, Volume: 5, Issue:2 Topics: Abscess; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Humans; Mezlocillin; Penicillin Resistance; Premedication; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Stomach; Surgical Wound Infection	1984
Ceftazidime in patients with Pseudomonas infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Abscess; Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Diarrhea; Drug Eruptions; Drug Resistance, Microbial; Female; Humans; Leukopenia; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Respiratory Tract Infections; Skin Diseases, Infectious; Uremia	1983
Ceftizoxime in the treatment of urinary tract infections. The Journal of urology, 1982, Volume: 128, Issue:6 Topics: Adolescent; Adult; Aged; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas Infections; Random Allocation; Urinary Tract Infections	1982
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections	1983
Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis. The Journal of pediatrics, 1983, Volume: 103, Issue:2 Topics: Acute Disease; Adolescent; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Female; Humans; Kinetics; Lung Diseases; Male; Pseudomonas Infections	1983
Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Bronchiectasis; Bronchitis; Ceftazidime; Cephalosporins; Humans; Injections, Intramuscular; Kinetics; Microbial Sensitivity Tests; Pseudomonas Infections; Recurrence; Sputum; Time Factors	1983
Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Carbenicillin; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Penicillin Resistance; Prospective Studies; Pseudomonas Infections; Random Allocation; Respiratory Function Tests; Respiratory Tract Infections; Tobramycin	1983
Ceftazidime: aspects of efficacy and tolerance. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Coombs Test; Enterobacteriaceae Infections; Eosinophilia; Humans; Liver Function Tests; Neutropenia; Pseudomonas Infections; Staphylococcal Infections	1983
A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Escherichia coli Infections; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections	1983
A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adult; Aged; Ceftazidime; Cephalosporins; Drug Administration Schedule; Enterobacteriaceae Infections; Female; Humans; Liver Function Tests; Male; Middle Aged; Pseudomonas Infections; Random Allocation; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections	1983
[Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa]. Hinyokika kiyo. Acta urologica Japonica, 1983, Volume: 29, Issue:9 Topics: Adult; Aged; Cefsulodin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pseudomonas Infections; Urinary Tract Infections	1983
[Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures]. Deutsche medizinische Wochenschrift (1946), 1983, Sep-02, Volume: 108, Issue:35 Topics: Ceftazidime; Cephalosporins; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	1983
[New cephalosporin with favorable pharmacokinetic properties]. MMW, Munchener medizinische Wochenschrift, 1983, Sep-02, Volume: 125, Issue:35 Topics: Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Pseudomonas Infections	1983
Cefsulodin sodium therapy in cystic fibrosis patients. Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:1 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	1984
[The clinical efficacy of cefsulodin to the infection of otorhinolaryngological field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adult; Cefsulodin; Cephalosporins; Chronic Disease; Clinical Trials as Topic; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Otitis Media; Otorhinolaryngologic Diseases; Pseudomonas Infections	1982
[Experimental and clinical evaluation of cefsulodin in the field of pediatric infection]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Adolescent; Age Factors; Cefsulodin; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections	1982
[Basic and clinical evaluation on cefsulodin in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adult; Cefsulodin; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	1982
Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Adolescent; Adult; Carbapenems; Ceftazidime; Cephalosporins; Child, Preschool; Cystic Fibrosis; Drug Tolerance; Humans; Liver; Meropenem; Microbial Sensitivity Tests; Nausea; Pseudomonas Infections; Spirometry; Sputum; Thienamycins; Transaminases; Treatment Outcome; Vomiting	1995
Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Pseudomonas Infections	1995
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:11 Topics: Adult; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross-Over Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Serum Bactericidal Test	1995
Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Adolescent; Alanine Transaminase; Blood Sedimentation; Body Weight; Ceftazidime; Cephalosporins; Child; Creatinine; Cystic Fibrosis; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Hemoglobins; Humans; Leukocyte Count; Lung; Lung Diseases; Lung Volume Measurements; Male; Neutrophils; Patient Readmission; Platelet Count; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Ventilation; Recurrence; Respiratory Function Tests; Time Factors; Treatment Outcome; Veins; Vital Capacity	1998
Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis. Archives of disease in childhood, 1998, Volume: 78, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Pseudomonas Infections; Sputum; Statistics, Nonparametric; Tobramycin	1998
[Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis]. Pathologie-biologie, 1998, Volume: 46, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Pneumonia, Bacterial; Pseudomonas Infections; Tobramycin	1998
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA, 1998, Oct-14, Volume: 280, Issue:14 Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1998
The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1999, Volume: 237, Issue:3 Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Safety; Treatment Outcome; Visual Acuity	1999
Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis? Australian and New Zealand journal of medicine, 1999, Volume: 29, Issue:1 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin	1999
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Pediatric pulmonology, 2001, Volume: 31, Issue:5 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome	2001
[Cephradine in urology]. MMW, Munchener medizinische Wochenschrift, 1977, Nov-25, Volume: 119, Issue:47 Topics: Adolescent; Adult; Aged; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Evaluation; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Streptococcal Infections; Urinary Tract Infections	1977
A preliminary report on cephradine. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1975, Aug-02, Volume: 49, Issue:33 Topics: Administration, Oral; Adolescent; Adult; Aged; Candidiasis; Cephalosporins; Cephradine; Escherichia coli Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Proteus Infections; Pseudomonas Infections; Urinary Tract Infections	1975
Cephalosporin therapeutics in cystic fibrosis. The Journal of pediatrics, 1986, Volume: 108, Issue:5 Pt 2 Topics: Cefsulodin; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Humans; Kinetics; Lung Diseases; Pseudomonas Infections; Structure-Activity Relationship	1986
[Cefazolin. 3. Double blind controlled trial in urinary tract infections]. The Japanese journal of antibiotics, 1972, Volume: 25, Issue:2 Topics: Adult; Cephaloridine; Cephalosporins; Clinical Trials as Topic; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Klebsiella pneumoniae; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Proteus Infections; Proteus mirabilis; Proteus vulgaris; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections	1972

Other Studies

512 other study(ies) available for cephalosporin c and Infections, Pseudomonas

Article	Year
Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; Cephalosporins; Endocarditis; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report. Journal of global antimicrobial resistance, 2021, Volume: 27 Topics: Cefiderocol; Cephalosporins; COVID-19; Empyema, Pleural; Humans; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015-2018. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 112 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States	2021
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:2 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Imipenem; Jupiter; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 113 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam	2021
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model. Scientific reports, 2021, 11-12, Volume: 11, Issue:1 Topics: Anti-Bacterial Agents; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2022, 01-18, Volume: 66, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
In vitro activity of ceftolozane/tazobactam against Gram-negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries-SMART 2017-2019. Journal of global antimicrobial resistance, 2022, Volume: 29 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Meropenem; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Thailand	2022
Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections. Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Successful cefiderocol therapy of severe infections due to difficult-to-treat Pseudomonas aeruginosa in two allogeneic hematopoietic stem cell transplantation recipients. Annals of hematology, 2022, Volume: 101, Issue:6 Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. The Journal of antimicrobial chemotherapy, 2022, 03-31, Volume: 77, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2022
In-vitro activity of ceftolozane/tazobactam against recent clinical bacterial isolates from two Saudi Arabian hospitals. Journal of infection and public health, 2022, Volume: 15, Issue:4 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Saudi Arabia; Tazobactam	2022
Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis. The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6 Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Cerebral Ventriculitis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experience. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:7 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam; Tertiary Care Centers	2022
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa. Scientific reports, 2022, 03-15, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2022
Drug resistance rates of difficult to treat Pseudomonas aeruginosa isolates to ceftolozane-tazobactam and ceftazidime-avibactam from a tertiary hospital, Singapore. Pathology, 2022, Volume: 54, Issue:7 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Singapore; Tazobactam; Tertiary Care Centers	2022
Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States	2022
Therapeutic Drug Monitoring and Prolonged Infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa Infections: An Observational Study. European journal of drug metabolism and pharmacokinetics, 2022, Volume: 47, Issue:4 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Monitoring; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy. Journal of global antimicrobial resistance, 2022, Volume: 30 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2022, 09-30, Volume: 77, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Borinic Acids; Carboxylic Acids; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Cyclooctanes; Humans; Imipenem; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
The plethora of resistance mechanisms in Pseudomonas aeruginosa: transcriptome analysis reveals a potential role of lipopolysaccharide pathway proteins to novel β-lactam/β-lactamase inhibitor combinations. Journal of global antimicrobial resistance, 2022, Volume: 31 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Gene Expression Profiling; Humans; Lactams; Lipopolysaccharides; Microbial Sensitivity Tests; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams. mBio, 2022, 10-26, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporinase; Cephalosporins; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study. Journal of infection and public health, 2022, Volume: 15, Issue:10 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2022
Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2022, 10-18, Volume: 66, Issue:10 Topics: Anti-Bacterial Agents; Aspartic Acid; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporinase; Cephalosporins; Glycine; Humans; Microbial Sensitivity Tests; Phenylalanine; Pseudomonas aeruginosa; Pseudomonas Infections; Serine; Tazobactam	2022
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa. Scientific reports, 2022, 10-07, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Monobactams; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa - Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 125 Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Ceftolozane/Tazobactam and Ceftazidime/Avibactam: An Italian Multi-center Retrospective Analysis of Safety and Efficacy in Children With Hematologic Malignancies and Multi-drug Resistant Gram-negative Bacteria Infections. The Pediatric infectious disease journal, 2022, 12-01, Volume: 41, Issue:12 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2022
Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2023
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland-SMART 2017-2020. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Czech Republic; Humans; Hungary; Imipenem; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients. Microbiology spectrum, 2023, 02-14, Volume: 11, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Child; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales. Journal of global antimicrobial resistance, 2023, Volume: 32 Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Escherichia coli; Humans; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Biochemical Insights into Imipenem Collateral Susceptibility Driven by Antimicrobial agents and chemotherapy, 2023, 02-16, Volume: 67, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China. International journal of antimicrobial agents, 2023, Volume: 61, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021). International journal of antimicrobial agents, 2023, Volume: 61, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020. International journal of antimicrobial agents, 2023, Volume: 61, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections. The Journal of antimicrobial chemotherapy, 2023, 05-03, Volume: 78, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporinase; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021. The Journal of infection, 2023, Volume: 87, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PloS one, 2023, Volume: 18, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2023
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Doripenem; Humans; Imipenem; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Susceptibility of ceftolozane/tazobactam against multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa. The new microbiologica, 2023, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2023, 07-05, Volume: 78, Issue:7 Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2023
Antimicrobial resistance of Pseudomonas aeruginosa in a cystic fibrosis population after introduction of a novel cephalosporin/β-lactamase inhibitor combination. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2023, Volume: 131, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporinase; Cephalosporins; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Successful Use of Cefepime-Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia. Antimicrobial agents and chemotherapy, 2023, 06-14 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cephalosporins; Humans; Microbial Sensitivity Tests; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy	2023
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity. International journal of antimicrobial agents, 2023, Volume: 62, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Biofilms; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin	2023
Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia. Pathology, 2023, Volume: 55, Issue:5 Topics: Adult; Anti-Bacterial Agents; Australia; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Antimicrobial agents and chemotherapy, 2023, 08-17, Volume: 67, Issue:8 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy	2023
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. Antimicrobial agents and chemotherapy, 2023, 08-17, Volume: 67, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Cohort Studies; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2023
Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infection and immunity, 2023, 08-16, Volume: 91, Issue:8 Topics: Anti-Bacterial Agents; Bacteriophages; Biofilms; Cephalosporins; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Phages	2023
Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis p Annals of clinical microbiology and antimicrobials, 2023, Jul-05, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Compassionate Use Trials; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Monobactams; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis	2023
Cefiderocol activity is compromised by acquired extended-spectrum oxacillinases in Pseudomonas aeruginosa. International journal of antimicrobial agents, 2023, Volume: 62, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2023
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model. The Journal of antimicrobial chemotherapy, 2023, 09-05, Volume: 78, Issue:9 Topics: Anti-Bacterial Agents; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin	2023
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey. The Journal of antimicrobial chemotherapy, 2019, 11-01, Volume: 74, Issue:11 Topics: Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; O Antigens; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Serogroup; Serotyping; Spain; Tazobactam; Whole Genome Sequencing	2019
Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar. The Journal of antimicrobial chemotherapy, 2019, 12-01, Volume: 74, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Qatar; Tazobactam; Whole Genome Sequencing	2019
Econometric ARIMA methodology to elucidate the evolution of trends in nosocomial antimicrobial resistance rates in the European Union. International journal of antimicrobial agents, 2020, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; European Union; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Models, Econometric; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections	2020
Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 07-11, Volume: 71, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2020
Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report. Pharmacotherapy, 2019, Volume: 39, Issue:11 Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Humans; Intraabdominal Infections; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2019
Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model. The Journal of antimicrobial chemotherapy, 2020, 01-01, Volume: 75, Issue:1 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cefepime; Cephalosporins; Cyclooctanes; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Lung; Mice; Microbial Sensitivity Tests; Neutropenia; Piperidines; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms	2020
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme. Journal of global antimicrobial resistance, 2020, Volume: 21 Topics: Asia; Cephalosporins; Europe; Female; Global Health; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Islands; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Sepsis; Skin Diseases, Bacterial; Tazobactam	2020
Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies. Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Critical Illness; Female; Hemodiafiltration; Humans; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections	2019
Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; China; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	2020
Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2020, 01-01, Volume: 75, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Biofilms; Cephalosporins; Cystic Fibrosis; Drug Synergism; Humans; Microbial Sensitivity Tests; Middle Aged; Nitric Oxide Donors; Prodrugs; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult	2020
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Intraabdominal Infections; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections	2020
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience. Infection, 2020, Volume: 48, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome	2020
Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data? Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Osteomyelitis; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores	2020
Ceftolozane/Tazobactam Treatment of Multidrug-resistant Pseudomonas aeruginosa Infections in Children. The Pediatric infectious disease journal, 2020, Volume: 39, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome; Young Adult	2020
Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; Cephalosporins; China; Drug Combinations; Drug Misuse; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Inappropriate Prescribing; India; Microbial Sensitivity Tests; Patient Care; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam	2020
Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy. Enfermedades infecciosas y microbiologia clinica (English ed.), 2020, Volume: 38, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary. Acta microbiologica et immunologica Hungarica, 2020, Mar-26, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Hungary; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation. Transplantation proceedings, 2020, Volume: 52, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Transplantation; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2020, 07-01, Volume: 75, Issue:7 Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United State Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 06-15, Volume: 72, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States	2021
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany. International journal of antimicrobial agents, 2020, Volume: 55, Issue:6 Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece. The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Activity of ceftolozane-tazobactam and comparators when tested against bacterial surveillance isolates collected from patients at risk of infections caused by resistant gram-negative pathogens. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:1 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunocompromised Host; Inpatients; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18. The Journal of antimicrobial chemotherapy, 2020, 10-01, Volume: 75, Issue:10 Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Europe; Europe, Eastern; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Ceftolozane and tazobactam for the treatment of hospital acquired pneumonia. Expert review of anti-infective therapy, 2020, Volume: 18, Issue:12 Topics: Anti-Bacterial Agents; Cephalosporins; Healthcare-Associated Pneumonia; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection. The Journal of antimicrobial chemotherapy, 2020, 11-01, Volume: 75, Issue:11 Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosa. American journal of infection control, 2021, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Secondary Prevention	2021
Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitis. Infection, 2021, Volume: 49, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Meningitis; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 12-06, Volume: 73, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Tazobactam	2021
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections. The Journal of antimicrobial chemotherapy, 2021, 01-01, Volume: 76, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS. The Journal of antimicrobial chemotherapy, 2021, 01-19, Volume: 76, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam	2021
Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa Isolates. Journal of clinical microbiology, 2021, 01-21, Volume: 59, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Diagnostic microbiology and infectious disease, 2021, Volume: 99, Issue:2 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2021
Amending the Efficiency of Antimicrobials against Multidrug-Resistant Pseudomonas aeruginosa by Low-Frequency Magnetic Fields. Bulletin of experimental biology and medicine, 2020, Volume: 170, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Fields; Microbial Sensitivity Tests; Penicillins; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones	2020
Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Spain; Tazobactam; Treatment Outcome	2021
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update. Pediatric pulmonology, 2021, Volume: 56, Issue:6 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Humans; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Real life experience with ceftolozane/tazobactam therapy for Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Cephalosporins; Comorbidity; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Tazobactam	2021
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018). Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam	2021
Ceftolozane/tazobactam for Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis adult patients: a case series. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:10 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Humans; Italy; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam; Young Adult	2021
Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2021, Volume: 92 Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Diabetic Foot; Drug Resistance; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Trends of Antimicrobial Resistance and Combination Susceptibility Testing of Multidrug-Resistant Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients: a 10-Year Update. Antimicrobial agents and chemotherapy, 2021, 05-18, Volume: 65, Issue:6 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
What place does ceftolozane/tazobactam have in the treatment of complicated urinary-tract infections? Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:11 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2021
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:11 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France. Infectious diseases now, 2021, Volume: 51, Issue:6 Topics: Adult; Cephalosporins; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021, Volume: 127, Issue:4 Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulfonamides; Young Adult	2021
Compassionate use of cefiderocol for VIM metallo-β-lactamase-producing Pseudomonas aeruginosa infection in a toddler with Burkitt lymphoma. Journal of global antimicrobial resistance, 2021, Volume: 26 Topics: beta-Lactamases; Burkitt Lymphoma; Cefiderocol; Cephalosporins; Child, Preschool; Compassionate Use Trials; Humans; Pseudomonas Infections	2021
Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump. Antimicrobial agents and chemotherapy, 2021, 07-16, Volume: 65, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporinase; Cephalosporins; COVID-19; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; SARS-CoV-2	2021
Trends in Antipseudomonal Agent Use Based on the 2006 to 2015 Sales Data in Japan. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Commerce; Drug Utilization; Fluoroquinolones; Humans; Japan; Penicillins; Pseudomonas Infections	2021
[Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:5 Topics: Aftercare; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Discharge; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2021
Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2021, 09-15, Volume: 76, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Phenotypic/Genotypic Profile of OXA-10-Like-Harboring, Carbapenem-Resistant Pseudomonas aeruginosa: Using Validated Pharmacokinetic/Pharmacodynamic Antimicrobial agents and chemotherapy, 2021, 09-17, Volume: 65, Issue:10 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Humans; Mice; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections	2021
In vitro characterization of Pseudomonas aeruginosa recovered in Portugal from low respiratory tract infections in ICU patients (STEP Study). FEMS microbiology letters, 2021, 08-12, Volume: 368, Issue:15 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam	2021
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization. Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Female; Humans; Male; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2017
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases. The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections	2017
Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2017, Volume: 30, Issue:3 Topics: Acute-Phase Proteins; Aged; Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2017
Successful treatment of multidrug-resistant BMJ case reports, 2017, Mar-31, Volume: 2017 Topics: Cephalosporins; Cystectomy; Debridement; Drug Resistance, Multiple, Bacterial; Fistula; Humans; Male; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas Infections; Pubic Symphysis; Tazobactam; Treatment Outcome	2017
Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa. International journal of antimicrobial agents, 2017, Volume: 49, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy; Tazobactam; Treatment Outcome; Young Adult	2017
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam. Journal of global antimicrobial resistance, 2017, Volume: 9 Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome	2017
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy. The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fractures, Bone; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2017
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins update. Pediatric pulmonology, 2017, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Humans; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections	2017
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Cefiderocol; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections	2017
Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens. International journal of antimicrobial agents, 2017, Volume: 50, Issue:6 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Siderophores; Skin Diseases, Bacterial; Treatment Outcome; Urinary Tract Infections	2017
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study. BMC infectious diseases, 2017, 07-17, Volume: 17, Issue:1 Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins	2017
Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Catheter-Related Infections; Ceftazidime; Cephalosporins; Cross Infection; Drug Combinations; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins	2017
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin	2017
Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Penicillanic Acid; Polymorphism, Single Nucleotide; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Wound Infection	2017
Role of inducers in detection of The Indian journal of medical research, 2017, Volume: 145, Issue:5 Topics: Bacterial Proteins; beta-Lactamases; Cefoxitin; Cephalosporin Resistance; Cephalosporins; DNA Fingerprinting; Humans; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections	2017
Susceptibility of MDR Pseudomonas aeruginosa to ceftolozane/tazobactam and comparison of different susceptibility testing methods. The Journal of antimicrobial chemotherapy, 2017, Nov-01, Volume: 72, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Cytoskeletal Proteins; Drug Resistance, Multiple, Bacterial; Germany; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2017
Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam. Future microbiology, 2017, Volume: 12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Male; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2017
Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Gene Expression; Humans; Los Angeles; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins	2017
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Genome, Bacterial; Humans; Male; Middle Aged; Penicillanic Acid; Pennsylvania; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam; Young Adult	2017
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazoba Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins	2018
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant. Infection, 2018, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Penicillanic Acid; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/L. The Journal of antimicrobial chemotherapy, 2017, 10-01, Volume: 72, Issue:10 Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2017
Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates. Journal of global antimicrobial resistance, 2017, Volume: 11 Topics: Bacteremia; Cephalosporins; Drug Resistance, Bacterial; Humans; Immunocompromised Host; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2017
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes. International journal of antimicrobial agents, 2018, Volume: 51, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome	2018
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers. The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Italy; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Whole Genome Sequencing	2018
In vitro activity of ceftolozane/tazobactam versus antimicrobial non-susceptible Pseudomonas aeruginosa clinical isolates including MDR and XDR isolates obtained from across Canada as part of the CANWARD study, 2008-16. The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3 Topics: Canada; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitalization; Humans; Isoenzymes; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Plasmids; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Retrospective Studies; Tazobactam; United States	2018
Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2018, 04-01, Volume: 73, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosa. Journal of global antimicrobial resistance, 2018, Volume: 13 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Tazobactam; Urinary Tract Infections	2018
Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers	2018
Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients. Infection, 2018, Volume: 46, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Oregon; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2018
Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program. International journal of antimicrobial agents, 2018, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Humans; Infusions, Parenteral; Lung Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Outpatients; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections. Infection, 2018, Volume: 46, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Female; Follow-Up Studies; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam; Treatment Failure; Treatment Outcome; Young Adult	2018
Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection. International journal of antimicrobial agents, 2018, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity, Morbid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2018
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm. International journal of antimicrobial agents, 2018, Volume: 52, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; beta-Lactamases; Ceftazidime; Cephalosporins; Clone Cells; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Survival Analysis; Tazobactam	2018
Ceftolozane-tazobactam for the treatment of multidrug-resistant American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018, May-01, Volume: 75, Issue:9 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Tazobactam; Treatment Outcome	2018
Ceftolozane-tazobactam resistance induced in vivo during the treatment of MDR Pseudomonas aeruginosa pneumonia. Expert review of anti-infective therapy, 2018, Volume: 16, Issue:5 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018
Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients. Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam	2018
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the Program to Assess Ceftolozane- Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:2 Topics: Anti-Infective Agents; Bacteremia; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States	2018
Postoperative soft-tissue infection due to multidrug-resistant Pseudomonas aeruginosa: usefulness of ceftolozane-tazobactam. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018, Volume: 31, Issue:4 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam; Treatment Outcome	2018
Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:11 Topics: Aged; Cephalosporins; Drug Resistance, Multiple, Bacterial; Factor Analysis, Statistical; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam	2018
Necrotizing Otitis Externa-Analysis of 83 Cases: Clinical Findings and Course of Disease. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2019, Volume: 40, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Disease Progression; Female; Hospitalization; Humans; Male; Middle Aged; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Retrospective Studies; Tertiary Care Centers; Treatment Outcome	2019
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 05-17, Volume: 68, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Tazobactam	2019
Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin. The Journal of antimicrobial chemotherapy, 2019, 01-01, Volume: 74, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; Treatment Outcome	2019
Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Gene Expression; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2019
[Ecthyma gangrenosum]. The Pan African medical journal, 2018, Volume: 30 Topics: Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Diagnosis, Differential; Ecthyma; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2018
Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia. Pathology, 2018, Volume: 50, Issue:7 Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Queensland; Tazobactam	2018
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. International journal of antimicrobial agents, 2019, Volume: 53, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Tazobactam; Treatment Outcome; Urinary Tract Infections	2019
Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 05-17, Volume: 68, Issue:11 Topics: Aged; Anti-Bacterial Agents; Aortic Valve; beta-Lactamases; Cefiderocol; Cephalosporins; Colistin; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Female; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2019
Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. International journal of antimicrobial agents, 2019, Volume: 53, Issue:4 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Fluoroquinolones; France; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Practice Patterns, Physicians'; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Standard of Care	2019
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam	2019
Activity of Ceftolozane/Tazobactam Against Gram-Negative Rods of the Family Enterobacteriaceae and Pseudomonas Spp. Isolated from Onco-Hematological Patients Hospitalized in a Clinical Hospital in Poland. Medical science monitor : international medical journal of experimental and clinical research, 2019, Jan-10, Volume: 25 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals; Humans; Microbial Sensitivity Tests; Patients; Poland; Pseudomonas; Pseudomonas Infections; Tazobactam	2019
Ceftolozane-Tazobactam Pharmacokinetics during Extracorporeal Membrane Oxygenation in a Lung Transplant Recipient. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Extracorporeal Membrane Oxygenation; Female; Humans; Lung Transplantation; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Transplant Recipients	2019
Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model. International journal of antimicrobial agents, 2019, Volume: 53, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biofilms; Cephalosporins; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2019
Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa. Journal of paediatrics and child health, 2019, Volume: 55, Issue:8 Topics: Cephalosporins; Child, Preschool; Endocarditis, Bacterial; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2019
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Young Adult	2019
Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients. International journal of antimicrobial agents, 2019, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Scotland; Tazobactam; Whole Genome Sequencing	2019
A Combination Antibiogram Evaluation for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States	2019
A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Humans; Hydrolysis; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2019
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa. Journal of medical microbiology, 2019, Volume: 68, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States	2019
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with BMJ open, 2019, 05-24, Volume: 9, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; International Cooperation; Logistic Models; Multicenter Studies as Topic; Neoplasms; Neutropenia; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Retrospective Studies; Tazobactam; Time Factors	2019
ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2019, 07-01, Volume: 74, Issue:7 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2019
Use of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019, Apr-08, Volume: 76, Issue:8 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2019
Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone. The Journal of hospital infection, 2020, Volume: 104, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10 Topics: Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Whole Genome Sequencing	2019
Optic nerve involvement from Pseudomonas aeruginosa -associated skull base osteomyelitis. JAMA ophthalmology, 2013, Volume: 131, Issue:2 Topics: Aged; Anti-Bacterial Agents; Blindness; Cefepime; Cephalosporins; Eye Infections, Bacterial; Humans; Magnetic Resonance Imaging; Male; Meropenem; Middle Aged; Optic Nerve Diseases; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Skull Base; Thienamycins; Visual Acuity	2013
Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies	2013
Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem. International journal of clinical pharmacy, 2013, Volume: 35, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Brain Diseases; Cefepime; Cephalosporins; Female; Hospitals, University; Humans; Infusions, Intravenous; Japan; Male; Meropenem; Neurotoxicity Syndromes; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Insufficiency; Retrospective Studies; Risk; Seizures; Staphylococcal Infections; Staphylococcus aureus; Thienamycins	2013
When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents. Clinical therapeutics, 2013, Volume: 35, Issue:6 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Drug Costs; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2013
In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Anti-Bacterial Agents; Canada; Ceftazidime; Cephalosporins; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2013
Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Analysis	2015
Comparison of efficiency of intravitreal ceftazidime and intravitreal cefepime in the treatment of experimental Pseudomonas aeruginosa endophthalmitis. Indian journal of ophthalmology, 2013, Volume: 61, Issue:9 Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Treatment Outcome; Vitreous Body	2013
Extended Infusion Cefepime. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:8 Topics: Anti-Bacterial Agents; Cephalosporins; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections	2013
Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Retrospective Studies	2014
Late manifestation of a driveline infection after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2014, Volume: 33, Issue:3 Topics: Abdomen; Anti-Bacterial Agents; Cefepime; Cephalosporins; Debridement; Device Removal; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Middle Aged; Polyethylene Terephthalates; Proteus Infections; Pseudomonas Infections; Radiography, Abdominal; Surgical Wound Infection; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2014
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia. International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure	2014
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins	2014
Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6')-Iae/AAC(6')-Ib. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:9 Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Inosine Monophosphate; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2014
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12). The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2014
Osteomyelitis of the clavicle following to a pacemaker implantation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:11 Topics: Anti-Bacterial Agents; Cardiac Pacing, Artificial; Cefepime; Cephalosporins; Ciprofloxacin; Clavicle; Drug Therapy, Combination; Equipment Design; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pacemaker, Artificial; Pseudomonas aeruginosa; Pseudomonas Infections	2014
In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: comparison with ceftazidime, piperacillin/tazobactam and imipenem. International journal of antimicrobial agents, 2014, Volume: 44, Issue:3 Topics: Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Ceftazidime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Female; Humans; Imipenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Treatment Outcome	2014
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011. The Journal of antibiotics, 2015, Volume: 68, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins	2015
Integron-borne transmission of VEB-1 extended-spectrum β-lactamase in Pseudomonas aeruginosa in a tertiary care hospital in India. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Transfer, Horizontal; Humans; India; Microbial Sensitivity Tests; Plasmids; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers; Tertiary Healthcare	2014
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections	2014
Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model. International journal of antimicrobial agents, 2014, Volume: 44, Issue:6 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Disease Models, Animal; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thigh	2014
Efficacy of anti-pseudomonal antibiotics: need to reconsider the empirical use of cefepime. The Indian journal of medical research, 2014, Volume: 140, Issue:4 Topics: Aged; Aged, 80 and over; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	2014
Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens. Pharmacotherapy, 2015, Volume: 35, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Heart-Assist Devices; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Time Factors; Treatment Outcome	2015
Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study. Anaesthesia, critical care & pain medicine, 2015, Volume: 34, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies	2015
Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Sep-01, Volume: 61, Issue:5 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2015
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:5 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins	2017
In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study. International journal of antimicrobial agents, 2015, Volume: 46, Issue:5 Topics: Academic Medical Centers; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam	2015
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration. Antimicrobial agents and chemotherapy, 2015, Dec-28, Volume: 60, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Critical Illness; Drug Resistance, Multiple, Bacterial; Hemofiltration; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Prospective Studies; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2015
Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Computer Simulation; Creatinine; Drug Dosage Calculations; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections	2016
Tissue penetration and exposure of cefepime in patients with diabetic foot infections. International journal of antimicrobial agents, 2016, Volume: 47, Issue:3 Topics: Cefepime; Cephalosporins; Diabetes Mellitus; Foot Diseases; Humans; Pseudomonas aeruginosa; Pseudomonas Infections	2016
In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa in the planktonic and biofilm states. Diagnostic microbiology and infectious disease, 2016, Volume: 85, Issue:3 Topics: Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; Biofilms; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2016
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. The Pediatric infectious disease journal, 2016, Volume: 35, Issue:9 Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Leukemia; Male; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2016
Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:8 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tokyo	2016
Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration. International journal of antimicrobial agents, 2016, Volume: 48, Issue:3 Topics: Aged; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; Cephalosporins; Chromatography, High Pressure Liquid; Critical Illness; Drug Resistance, Multiple, Bacterial; Hemofiltration; Humans; Male; Penicillanic Acid; Plasma; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome; United States	2016
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa. Pharmacotherapy, 2016, Volume: 36, Issue:10 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2016
Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran. Infectious disorders drug targets, 2016, Volume: 16, Issue:3 Topics: Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections	2016
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Belgium; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Gene Expression; Germany; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; United Kingdom	2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? Expert review of anti-infective therapy, 2016, Volume: 14, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2016
Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam. Infection, 2017, Volume: 45, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Off-Label Use; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2017
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; France; Gene Expression; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals; Humans; Microbial Sensitivity Tests; Monobactams; Mutation; Penicillins; Phylogeny; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Spain	2016
Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Salvage Therapy; Shock, Septic; Survival Analysis; Tazobactam	2017
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam	2017
A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime. Diagnostic microbiology and infectious disease, 2017, Volume: 87, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Multivariate Analysis; Propensity Score; Pseudomonas aeruginosa; Pseudomonas Infections	2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15). The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Europe; Humans; Intraabdominal Infections; Israel; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Turkey; Urinary Tract Infections	2017
Infection in burn patients in a referral center in Colombia. Burns : journal of the International Society for Burn Injuries, 2017, Volume: 43, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Catheter-Related Infections; Central Venous Catheters; Cephalosporins; Child; Child, Preschool; Colombia; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Folliculitis; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Wound Infection; Young Adult	2017
Presentation, treatment, and clinical course of otogenic lateral sinus thrombosis. Acta oto-laryngologica, 2009, Volume: 129, Issue:7 Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Cephalosporins; Cholesteatoma, Middle Ear; Chronic Disease; Combined Modality Therapy; Comorbidity; Disease Progression; Enterococcus; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Heparin; Hospitals, Teaching; Humans; Lateral Sinus Thrombosis; Magnetic Resonance Angiography; Male; Mastoid; Mastoiditis; Neurologic Examination; Otitis Media; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Retrospective Studies; Young Adult	2009
Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive care medicine, 2009, Volume: 35, Issue:3 Topics: Adult; Cephalosporins; Critical Illness; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genes, Viral; Genotype; Humans; Intensive Care Units; Male; Pharynx; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rectum; Respiratory Mucosa	2009
Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa. Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 5 Topics: Anti-Bacterial Agents; Automation; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Genetic Predisposition to Disease; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections	2009
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. Digestive diseases and sciences, 2010, Volume: 55, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections	2010
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. Journal of critical care, 2010, Volume: 25, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Observation; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin; Young Adult	2010
Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates. International journal of antimicrobial agents, 2009, Volume: 34, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult	2009
Activity of cephalosporin CXA-101 (FR264205) and comparators against extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2 Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase. Journal of clinical microbiology, 2009, Volume: 47, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gene Expression; Genes, Bacterial; Hospitals; Humans; Integrons; Intensive Care Units; Male; Membrane Transport Proteins; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Spain	2009
Cefepime and all-cause mortality. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49, Issue:4 Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Humans; Pseudomonas Infections; Randomized Controlled Trials as Topic	2009
Class 1 integron containing metallo beta-lactamase gene blaIMP-1 in carbapenem-resistant Pseudomonas aeruginosa in Thailand. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:4 Topics: Amino Acid Sequence; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Integrons; Molecular Epidemiology; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand	2009
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins	2009
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Hairless; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus	2010
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2010
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections	2010
Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Spain	2010
Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2010
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA	2010
Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections	2010
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic	2010
Cefepime: an underrecognized cause of nonconvulsive status epilepticus. Journal of hospital medicine, 2010, Volume: 5, Issue:3 Topics: Aged; Anti-Bacterial Agents; Benzodiazepines; Cefepime; Cephalosporins; Female; Humans; Kidney Failure, Chronic; Pseudomonas aeruginosa; Pseudomonas Infections; Status Epilepticus	2010
Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7 Topics: Anti-Bacterial Agents; Biofilms; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Microbial Viability; Mutation; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	2010
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections	2010
The importance of pharmacokinetic consultation of cefepime treatment for Pseudomonas aeruginosa bacteremia: a case report of severe thermal burn injury. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Burns; Cefepime; Cephalosporins; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	2011
Antibiotic resistance in Pseudomonas aeruginosa related to quinolone formulary changes: an interrupted time series analysis. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Formularies, Hospital as Topic; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2011
Perioperative, postoperative, and prophylactic use of antibiotics in alloplastic total temporomandibular joint replacement surgery: a survey and preliminary guidelines. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:8 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacitracin; Biofilms; Cefazolin; Cephalosporins; Clindamycin; Device Removal; Disinfection; Gentamicins; Gram-Positive Bacterial Infections; Humans; Joint Prosthesis; Penicillins; Peptostreptococcus; Peroxides; Povidone-Iodine; Practice Guidelines as Topic; Practice Patterns, Dentists'; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temporomandibular Joint; Therapeutic Irrigation; Vancomycin	2011
Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Female; Gene Expression Profiling; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation, Missense; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction	2011
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. International journal of antimicrobial agents, 2011, Volume: 38, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States	2011
Cefepime-resistant Pseudomonas aeruginosa. Emerging infectious diseases, 2011, Volume: 17, Issue:6 Topics: Anti-Bacterial Agents; Case-Control Studies; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	2011
Effect of a cholesterol rich diet, recurrent infection and possible treatment modalities on the pulmonary vascular system: an experimental study. The West Indian medical journal, 2011, Volume: 60, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Cefepime; Cephalosporins; Cholesterol, Dietary; Diclofenac; Hypercholesterolemia; Pseudomonas Infections; Pulmonary Artery; Rats; Wine	2011
Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Western; Cefepime; Cephalosporins; Computer Simulation; Drug Administration Schedule; Drug Interactions; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tobramycin	2012
In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thigh	2012
Cefepime: a rare cause of encephalopathy. Internal medicine journal, 2012, Volume: 42, Issue:6 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Glomerular Filtration Rate; Humans; Neurotoxicity Syndromes; Osteomyelitis; Pseudomonas Infections; Respiration, Artificial	2012
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections	2012
The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection. PloS one, 2012, Volume: 7, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Prescriptions; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Survival Rate	2012
Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:1 Topics: Acute Disease; Animals; Anti-Infective Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Inflammation; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2013
In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thigh	2013
Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Critical Care; Cystic Fibrosis; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Infusion Pumps; Pseudomonas Infections; Pyridines; Syringes; Temperature	2002
Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporinase; Cephalosporins; Data Collection; Drug Resistance, Microbial; France; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections	2002
Squamous cell carcinoma associated with a periorbital mass in a veiled chameleon (Chamaeleo calyptratus). Veterinary ophthalmology, 2002, Volume: 5, Issue:3 Topics: Abscess; Animals; Carcinoma, Squamous Cell; Ceftazidime; Cephalosporins; Diagnosis, Differential; Eye Infections, Bacterial; Lizards; Neoplasm Recurrence, Local; Orbital Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections	2002
Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Colony Count, Microbial; Computer Simulation; Endotoxins; Female; Lipopolysaccharides; Microscopy, Phase-Contrast; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley	2003
Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa. Pharmacotherapy, 2003, Volume: 23, Issue:3 Topics: Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies	2003
[Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis]. Pathologie-biologie, 2003, Volume: 51, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2003
In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:8 Topics: Abscess; Animals; Area Under Curve; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections	2003
In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. Chemotherapy, 2003, Volume: 49, Issue:6 Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Lactams; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2003
Outbreak of Pseudomonas aeruginosa infections caused by commercial piercing of upper ear cartilage. JAMA, 2004, Feb-25, Volume: 291, Issue:8 Topics: Abscess; Adolescent; Adult; Cartilage Diseases; Cephalosporins; Child; Cohort Studies; Cosmetic Techniques; Data Collection; Disease Outbreaks; Disease Transmission, Infectious; DNA Fingerprinting; Ear Cartilage; Ear Deformities, Acquired; Ear, External; Equipment Contamination; Fluoroquinolones; Humans; Oregon; Otolaryngology; Pseudomonas aeruginosa; Pseudomonas Infections; Punctures; Wound Infection	2004
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins	2004
Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6 Topics: Alkylating Agents; Animals; Ceftazidime; Cephalosporins; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Female; Granulocyte Colony-Stimulating Factor; Mice; Neutropenia; Pneumonia, Bacterial; Pseudomonas Infections; Survival Analysis	2004
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:4 Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin	2004
Case report: Pseudomonas aeruginosa-related intervertebral discitis in a young boy with medulloblastoma. Journal of neuro-oncology, 2004, Volume: 68, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Back Pain; Biopsy, Fine-Needle; Bone Neoplasms; Cefepime; Cephalosporins; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Humans; Imipenem; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Medulloblastoma; Pseudomonas Infections; Thoracic Vertebrae; Treatment Outcome	2004
Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. International journal of urology : official journal of the Japanese Urological Association, 2004, Volume: 11, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Male; Methicillin Resistance; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Specimen Handling; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Urinary Tract Infections; Urine; Urologic Surgical Procedures	2004
n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: alpha-Linolenic Acid; Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fatty Acids, Unsaturated; Lipopolysaccharides; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis; Tumor Necrosis Factor-alpha	2004
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest, 2005, Volume: 127, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical	2005
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:8 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan	2005
Characteristics of Pseudomonas corneal infection related to orthokeratology. Cornea, 2005, Volume: 24, Issue:7 Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Cefmenoxime; Cefozopran; Cephalosporins; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections	2005
Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis. The Journal of infection, 2005, Volume: 51, Issue:4 Topics: Acyclovir; Ampicillin; Calcification, Physiologic; Cefepime; Cephalosporins; Community-Acquired Infections; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Humans; Meningitis, Bacterial; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin	2005
[Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Bronchial Diseases; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Staphylococcal Infections; Staphylococcus aureus	2005
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps. Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Membrane Transport Proteins; Meropenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Thienamycins; Thigh; Treatment Outcome	2007
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections	2006
Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Computer Simulation; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Hungary; Imipenem; Infusions, Intravenous; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2006
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Animals; beta-Lactamases; Burns; Cephalosporins; Drug Resistance, Multiple, Bacterial; Lung Diseases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections; Wound Infection	2007
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cefepime; Cephalosporins; Culture Media; Drug Resistance, Multiple; Fluoroquinolones; France; Hospitals, University; Humans; Incidence; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections	2008
In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:1 Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2008
[Clinical studies on combination therapy of cephem antibiotics in chronic complicated urinary tract polymicrobial infections due to Pseudomonas aeruginosa and other bacteria]. The Japanese journal of antibiotics, 1984, Volume: 37, Issue:9 Topics: Aged; Bacterial Infections; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pseudomonas Infections; Urinary Tract Infections	1984
Intravenous cefotaxime in children with bacterial meningitis. Lancet (London, England), 1980, Jan-12, Volume: 1, Issue:8159 Topics: Biological Availability; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; In Vitro Techniques; Infant; Infant, Newborn; Injections, Intravenous; Male; Meningitis; Meningitis, Haemophilus; Meningitis, Pneumococcal; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae	1980
Diarrhoea and annihilation of faecal flora associated with cefpiramide. Lancet (London, England), 1983, Feb-19, Volume: 1, Issue:8321 Topics: Cephalosporins; Child; Diarrhea; Feces; Humans; Pseudomonas Infections	1983
Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:4 Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections	1982
Gram-negative bacillary meningitis. New therapy and changing concepts. Archives of internal medicine, 1982, Volume: 142, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chloramphenicol; Enterobacteriaceae Infections; Humans; Meningitis; Moxalactam; Pseudomonas Infections	1982
[Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa]. Revista clinica espanola, 1982, Feb-28, Volume: 164, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections	1982
Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis. Archives of otolaryngology (Chicago, Ill. : 1960), 1982, Volume: 108, Issue:6 Topics: Aged; Cephalosporins; Cephamycins; Chronic Disease; Diabetes Complications; Female; Humans; Male; Mastoiditis; Middle Aged; Moxalactam; Otitis Externa; Otitis Media; Otitis Media, Suppurative; Pseudomonas Infections	1982
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs. The Journal of infectious diseases, 1982, Volume: 146, Issue:4 Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin	1982
Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections	1982
Gram-negative bacterial toe web infection: successful treatment with a new third generation cephalosporin. Journal of the American Academy of Dermatology, 1983, Volume: 8, Issue:2 Topics: Adult; Aged; Bacterial Infections; Cefoperazone; Cephalosporins; Enterobacteriaceae Infections; Foot Dermatoses; Humans; Male; Middle Aged; Proteus Infections; Pseudomonas Infections; Skin Diseases, Infectious; Streptococcal Infections; Toes	1983
[Studies on the combination action of sisomicin, gentamicin and piperacillin, cefmetazole against Pseudomonas aeruginosa and Serratia marcescens]. The Japanese journal of antibiotics, 1983, Volume: 36, Issue:1 Topics: Animals; Cefmetazole; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Drug Synergism; Gentamicins; Male; Mice; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Sisomicin	1983
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis. Clinical pediatrics, 1983, Volume: 22, Issue:9 Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Male; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin	1983
Perforated and gangrenous appendicitis: an analysis of antibiotic failures. The Journal of infectious diseases, 1983, Volume: 148, Issue:2 Topics: Anti-Bacterial Agents; Appendicitis; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefoperazone; Cephalosporins; Clindamycin; Drug Therapy, Combination; Female; Gangrene; Gentamicins; Humans; Male; Pseudomonas; Pseudomonas Infections; Rupture, Spontaneous	1983
Ceftazidime treatment in intensive care patients. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Abscess; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Eruptions; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections	1983
[Enzymatic stability in vivo of a new cephalosporin active against Pseudomonas aeruginosa: ceftazidime]. Presse medicale (Paris, France : 1983), 1984, Jun-02, Volume: 13, Issue:23 Topics: Adolescent; Ceftazidime; Cephalosporins; Humans; Male; Penicillinase; Pseudomonas aeruginosa; Pseudomonas Infections	1984
Antibiotics--their administration, choice and prophylactic use. Anaesthesia and intensive care, 1980, Volume: 8, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Penicillins; Polymyxins; Pseudomonas Infections; Streptococcal Infections	1980
[Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)]. La Nouvelle presse medicale, 1981, Feb-26, Volume: 10, Issue:8 Topics: Adult; Aged; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Meningitis; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections	1981
[Cefotaxime in the treatment of purulent meningitis in children (author's transl)]. La Nouvelle presse medicale, 1981, Feb-26, Volume: 10, Issue:8 Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Meningitis, Haemophilus; Pseudomonas Infections; Salmonella Infections	1981
[Cefotaxime in digestive tract infections (author's transl)]. La Nouvelle presse medicale, 1981, Feb-26, Volume: 10, Issue:8 Topics: Adult; Aged; Cefotaxime; Cephalosporins; Digestive System Diseases; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Staphylococcal Infections	1981
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections	1981
[Chemotherapy of severe bacterial infections in pediatrics]. Wiener klinische Wochenschrift. Supplementum, 1983, Volume: 142 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Clindamycin; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Meningitis; Metronidazole; Penicillin G; Pseudomonas Infections; Streptococcal Infections	1983
[Clinical use of new cephalosporins for severe infections in internal medicine]. Wiener klinische Wochenschrift. Supplementum, 1983, Volume: 142 Topics: Bacteroides Infections; Cefotaxime; Cefoxitin; Cephalosporins; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Staphylococcal Infections; Structure-Activity Relationship	1983
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs]. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious..., 1983, Volume: 254, Issue:2 Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam	1983
Treatment of Pseudomonas aeruginosa meningitis with ceftazidime. The Journal of antimicrobial chemotherapy, 1983, Volume: 11, Issue:2 Topics: Adolescent; Ceftazidime; Cephalosporins; Humans; Male; Meningitis; Pseudomonas Infections	1983
Ceftazidime therapy for serious infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Urinary Tract Infections	1983
Ceftazidime: a new approach in the treatment of moderate and severe infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Meningitis; Middle Aged; Peritonitis; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections	1983
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Child; Drug Resistance, Microbial; Eosinophilia; Female; Humans; Liver Function Tests; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections	1983
Ceftazidime in the therapy of serious Gram-negative bacillary infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Acute Kidney Injury; Adult; Aged; Anaphylaxis; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Wound Infection	1983
The treatment of bone infections with ceftazidime. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Acute Disease; Adult; Aged; Ceftazidime; Cephalosporins; Chronic Disease; Coombs Test; Female; Humans; Liver Function Tests; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections	1983
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Half-Life; Humans; Kinetics; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Tobramycin	1983
Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Kinetics; Male; Premedication; Probenecid; Pseudomonas Infections; Respiratory Tract Infections	1983
Experience with ceftazidime in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Pseudomonas Infections; Respiratory Tract Infections	1983
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Sulfamethoxazole; Tobramycin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1983
Ceftazidime - a significant advance in the treatment of cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Tobramycin	1983
Clinical pharmacology of ceftazidime in paediatrics. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Ceftazidime; Cephalosporins; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Male; Microbial Sensitivity Tests; Pseudomonas Infections; Respiratory Tract Infections; Tissue Distribution; Urinary Tract Infections	1983
Ceftazidime in the treatment of chronic suppurative otitis media in children. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Ceftazidime; Cephalosporins; Child, Preschool; Chronic Disease; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Otitis Media, Suppurative; Pseudomonas Infections; Recurrence	1983
Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Male; Neutrophils; Pseudomonas Infections; Recurrence; Respiratory Tract Infections	1983
Clinical studies on ceftazidime in surgery in Japan. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Ceftazidime; Cephalosporins; Escherichia coli Infections; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Pseudomonas Infections; Staphylococcal Infections; Surgical Wound Infection	1983
An open study of the use of ceftazidime in Gram-negative infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cystic Fibrosis; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Respiratory Tract Infections; Urinary Tract Infections; Wound Infection	1983
Clinical experience with ceftazidime in urology in Japan. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Humans; Japan; Male; Middle Aged; Pseudomonas Infections; Serratia marcescens; Urinary Tract Infections	1983
An open study of ceftazidime in the treatment of serious bacterial infection. The Journal of antimicrobial chemotherapy, 1983, Volume: 12, Issue:3 Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Salmonella Infections	1983
Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:2 Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pseudomonas Infections	1983
Successful treatment of Pseudomonas aeruginosa meningitis with ceftazidime. The Journal of infection, 1983, Volume: 7, Issue:3 Topics: Aged; Ceftazidime; Cephalosporins; Humans; Male; Meningitis; Pseudomonas Infections	1983
Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp. Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:3 Topics: Adolescent; C-Reactive Protein; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Time Factors; Urinary Tract Infections	1984
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adult; Aged; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis	1983
Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12, Issue:4 Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	1983
Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin. Scandinavian journal of infectious diseases, 1983, Volume: 15, Issue:3 Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	1983
Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria. Archives of internal medicine, 1984, Volume: 144, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Evaluation; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Infant; Lung Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1984
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs. The Journal of infectious diseases, 1984, Volume: 149, Issue:6 Topics: Agranulocytosis; Aminoglycosides; Animals; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Netilmicin; Neutropenia; Penicillin Resistance; Penicillins; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin	1984
[In vivo-acquired resistance to cefsulodin by a strain of Pseudomonas aeruginosa]. Pathologie-biologie, 1984, Volume: 32, Issue:5 Topics: Cefsulodin; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	1984
In vitro properties of ceftazidime, a highly active broad-spectrum cephalosporin with antipseudomonal activity. Clinical therapeutics, 1984, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections	1984
Ceftazidime disposition in acute and stable cystic fibrosis. Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:3 Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Cystic Fibrosis; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	1984
[In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa]. Schweizerische medizinische Wochenschrift, 1981, Mar-07, Volume: 111, Issue:10 Topics: Cefoperazone; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections	1981
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Annals of internal medicine, 1981, Volume: 94, Issue:6 Topics: Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas Infections	1981
The role of the laboratory in the planned use of cefoperazone for the treatment of difficult Pseudomonas infections. Drugs, 1981, Volume: 22 Suppl 1 Topics: Adult; Aged; Aortitis; Cefoperazone; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Pseudomonas; Pseudomonas Infections; Sepsis	1981
Moxalactam therapy for bacterial infections. Archives of internal medicine, 1981, Volume: 141, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship	1981
Interaction of moxalactam and gentamicin: in-vitro study with strains of Staphylococcus aureus and Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1982, Volume: 9, Issue:2 Topics: Cephalosporins; Cephamycins; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus	1982
[Laboratory and clinical studies on cefsulodin (author's transl)]. The Japanese journal of antibiotics, 1981, Volume: 34, Issue:10 Topics: Adult; Aged; Cefsulodin; Cephalosporins; Cystitis; Drug Evaluation; Female; Gentamicins; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections	1981
Cephalosporin antibiotic agents. The Medical journal of Australia, 1984, Sep-29, Volume: 141, Issue:7 Topics: Bacterial Infections; Cephalosporins; Costs and Cost Analysis; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Meningitis, Haemophilus; Pseudomonas Infections	1984
Basic design of beta-lactam antibiotics--cephalosporins. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Administration, Oral; Bacterial Infections; Bacteroides Infections; Cephalosporins; Humans; Injections; Pseudomonas Infections; Structure-Activity Relationship; Technology, Pharmaceutical	1984
Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta paediatrica Scandinavica, 1983, Volume: 72, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbenicillin; Cefsulodin; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Peak Expiratory Flow Rate; Pseudomonas Infections; Tobramycin	1983
[Topical administration of cefsulodin in postoperative Pseudomonas aeruginosa infection of the middle ears]. The Japanese journal of antibiotics, 1983, Volume: 36, Issue:9 Topics: Administration, Topical; Adolescent; Adult; Aged; Cefsulodin; Cephalosporins; Drug Evaluation; Female; Humans; Male; Otitis Media; Postoperative Complications; Pseudomonas Infections	1983
Penetration of cefsulodin into bronchial secretions. Chemotherapy, 1984, Volume: 30, Issue:4 Topics: Bronchi; Bronchoscopy; Cefsulodin; Cephalosporins; Humans; Kinetics; Pseudomonas Infections	1984
Gram-negative foot infections: antimicrobial therapy. The Journal of foot surgery, 1982,Fall, Volume: 21, Issue:3 Topics: Aged; Aminoglycosides; Bacteroides Infections; Cephalosporins; Drug Therapy, Combination; Foot Diseases; Humans; Male; Middle Aged; Penicillins; Proteus Infections; Proteus mirabilis; Pseudomonas Infections	1982
[Gram negative bacilli endocarditis ]. Pathologie-biologie, 1982, Volume: 30, Issue:6 Pt 2 Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Drug Therapy, Combination; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Penicillins; Prognosis; Pseudomonas Infections	1982
Gentamicin and cefsulodin efficacy in a rat abscess model. Surgery, gynecology & obstetrics, 1982, Volume: 155, Issue:3 Topics: Abscess; Anaerobiosis; Animals; Cefsulodin; Cephalosporins; Disease Models, Animal; Female; Gentamicins; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rats	1982
[Pseudomonas aeruginosa bacteriaemia: new clinical and therapeutic aspects ]. Pathologie-biologie, 1982, Volume: 30, Issue:6 Pt 2 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Penicillins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis	1982
Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin. Scandinavian journal of infectious diseases, 1982, Volume: 14, Issue:3 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Child; Cystic Fibrosis; Drug Evaluation; Female; Humans; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections	1982
[Gram negative infective endocarditis. Apropos of 27 cases]. Archives des maladies du coeur et des vaisseaux, 1982, Volume: 75, Issue:9 Topics: Adult; Aged; Brucellosis; Cephalosporins; Child; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Fusobacterium Infections; Haemophilus Infections; Heart Failure; Humans; Male; Middle Aged; Prognosis; Pseudomonas Infections; Shock, Septic	1982
Ceftazidime in the treatment of urinary tract infection. Current medical research and opinion, 1982, Volume: 8, Issue:4 Topics: Aged; Ceftazidime; Cephalosporins; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas Infections; Streptococcal Infections; Urinary Catheterization; Urinary Tract Infections	1982
[Clinical studies on cefsulodin in the field of pediatrics]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Age Factors; Cefsulodin; Cephalosporins; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections	1982
[Clinical evaluation of cefsulodin in the field of pediatrics]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Adolescent; Age Factors; Cefsulodin; Cephalosporins; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections	1982
[Experimental and clinical evaluation of cefsulodin in the pediatric field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Adolescent; Age Factors; Cefsulodin; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcus aureus	1982
Nosocomial pneumonia. Comprehensive therapy, 1981, Volume: 7, Issue:6 Topics: Aminoglycosides; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillin G; Pneumococcal Infections; Pneumonia; Pseudomonas Infections; Staphylococcal Infections	1981
Oral antibiotics in pedal infections. The Journal of foot surgery, 1980,Summer, Volume: 19, Issue:2 Topics: Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Erythromycin; Escherichia coli Infections; Foot Diseases; Humans; Penicillins; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Surgical Wound Infection	1980
New antimicrobials. British journal of hospital medicine, 1982, Volume: 27, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Cephalosporins; Humans; Penicillins; Pseudomonas Infections	1982
The new cephalosporins. Journal of the Iowa Medical Society, 1982, Volume: 72, Issue:6 Topics: Bacterial Infections; Cephalosporins; Chemical Phenomena; Chemistry; Humans; Pseudomonas Infections	1982
[The effectiveness of recent cephalosporins against urinary tract and wound infection bacteria including Pseudomonas aeruginosa]. Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete, 1982, Volume: 28, Issue:8 Topics: Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas Infections; Urinary Tract Infections; Wound Infection	1982
[Clinical studies on cefsulodin in the pediatric field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Administration, Intranasal; Adolescent; Age Factors; Cefsulodin; Cephalosporins; Child; Drug Evaluation; Female; Humans; Infant, Newborn; Injections, Intravenous; Male; Pseudomonas Infections; Sputum	1982
[Clinical evaluation of cefsulodin in Pseudomonas infections in children]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Adolescent; Age Factors; Cefsulodin; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Male; Pseudomonas Infections	1982
[Evaluation of cefsulodin in the field of pediatrics]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Age Factors; Cefsulodin; Cephalosporins; Child, Preschool; Drug Evaluation; Humans; Infant; Infusions, Parenteral; Male; Pseudomonas Infections	1982
[The experimental and clinical studies on cefsulodin in the pediatric field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Age Factors; Cefsulodin; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Male; Pseudomonas Infections	1982
[Clinical studies of cefsulodin in the pediatric field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Age Factors; Cefsulodin; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infusions, Parenteral; Injections, Intravenous; Kinetics; Pseudomonas Infections	1982
[Clinical application of cefsulodin in gravely ill children with Pseudomonas infection]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:11 Topics: Adolescent; Age Factors; Cefsulodin; Cephalosporins; Child; Drug Evaluation; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Pseudomonas Infections	1982
Selection of antimicrobial therapy. Instructional course lectures, 1982, Volume: 31 Topics: Anti-Bacterial Agents; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Osteomyelitis; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Surgical Wound Infection; Vascular Diseases	1982
[Transfer of cefsulodin into human otorrhea after intravenous administration]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adolescent; Adult; Aged; Cefsulodin; Cephalosporins; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Otitis Media; Pseudomonas Infections; Suppuration	1982
[Clinical evaluation of cefsulodin for the infection caused by P. aeruginosa in otorhinolaryngological field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Child; Drug Evaluation; Humans; Infusions, Parenteral; Male; Middle Aged; Otitis Media; Pseudomonas Infections; Suppuration	1982
[Clinical study of cefsulodin on infectious diseases in otorhinolaryngological field]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adult; Cefsulodin; Cephalosporins; Child; Drug Evaluation; Female; Humans; Male; Middle Aged; Otitis Media; Pseudomonas Infections	1982
[Clinical study of cefsulodin on Pseudomonas aeruginosa infections in otorhinolaryngology]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adult; Aged; Cefsulodin; Cephalosporins; Chronic Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Otitis Media; Pseudomonas Infections; Surgical Wound Infection	1982
[Clinical experience with cefsulodin in the field of otorhinolaryngology]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Cefsulodin; Cephalosporins; Chronic Disease; Drug Evaluation; Female; Humans; Male; Otitis Media; Pseudomonas Infections; Surgical Wound Infection	1982
[Basic and clinical studies on cefsulodin for the otorhinolaryngological infections]. The Japanese journal of antibiotics, 1982, Volume: 35, Issue:12 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Child; Drug Evaluation; Female; Humans; Male; Middle Aged; Otorhinolaryngologic Diseases; Pseudomonas Infections; Tissue Distribution	1982
Antipseudomonal activity of beta-lactam antibiotics. The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:4 Topics: Cephalosporins; Pseudomonas Infections	1981
[Clinical application of cefsulodin to Pseudomonas aeruginosa infections in the surgical field (author's transl)]. The Japanese journal of antibiotics, 1981, Volume: 34, Issue:4 Topics: Adult; Aged; Burns; Cefsulodin; Cephalosporins; Child; Drug Evaluation; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Surgical Wound Infection	1981
[Cefsulodine concentrations in cerebral ventricles during parenteral treatment of ventriculitis due to Pseudomonas aeruginosa (author's transl)]. La Nouvelle presse medicale, 1981, Oct-03, Volume: 10, Issue:35 Topics: Cefsulodin; Cephalosporins; Cerebral Ventricles; Encephalitis; Humans; Male; Middle Aged; Pseudomonas Infections	1981
[Treatment of Pseudomonas infections in children with cefsulodin (author's transl)]. Wiener medizinische Wochenschrift (1946), 1981, Oct-31, Volume: 131, Issue:20 Topics: Anti-Bacterial Agents; Cefsulodin; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Pseudomonas Infections	1981
New cephalosporins and related compounds. The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4 Topics: Cephalosporins; Humans; Pseudomonas Infections	1980
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections	1995
Postantibiotic effect of carbapenems against Pseudomonas aeruginosa. The Journal of antibiotics, 1995, Volume: 48, Issue:8 Topics: Animals; Ceftazidime; Cephalosporins; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1995
[A rare case of malignant otitis external in a non-diabetic patient]. Laryngo- rhino- otologie, 1995, Volume: 74, Issue:7 Topics: Aged; Ceftazidime; Cephalosporins; Diagnostic Imaging; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Osteomyelitis; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections	1995
Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis. Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:8 Topics: Animals; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Female; Imipenem; Kidney Calculi; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Bladder Calculi; Urinary Calculi; Urinary Tract Infections	1994
Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:3 Topics: Animals; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Microbial Sensitivity Tests; Pseudomonas Infections; Rabbits	1994
Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations. The Journal of antimicrobial chemotherapy, 1993, Volume: 32 Suppl B Topics: Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections	1993
Fever and neutropenia during intensive chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:7 Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Pseudomonas Infections; Vancomycin	1993
Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:1 Topics: Animals; Bacterial Infections; Cefozopran; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Muscular Diseases; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections	1993
Cephalosporins having a heterocyclic catechol in the C3 side chain. I. Enhancement of efficacy against gram-negative bacteria. The Journal of antibiotics, 1993, Volume: 46, Issue:5 Topics: Animals; Ceftazidime; Cephalosporins; Half-Life; Imipenem; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship	1993
Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin. The Journal of urology, 1996, Volume: 155, Issue:6 Topics: Animals; Antibodies, Monoclonal; Bacteremia; Cefsulodin; Cephalosporins; Combined Modality Therapy; Female; Flow Cytometry; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Neutropenia; Neutrophils; Phagocytosis; Pseudomonas Infections; Pyelonephritis	1996
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice. Journal of medical microbiology, 1996, Volume: 44, Issue:3 Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Escherichia coli Infections; Fluorouracil; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillins; Pseudomonas Infections; Survival Analysis	1996
Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Filgrastim; Gentamicins; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Platelet Aggregation Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Ticlopidine	1996
Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance. Annals of the Academy of Medicine, Singapore, 1995, Volume: 24, Issue:6 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol Resistance; Contact Lenses; Corneal Ulcer; Drug Resistance, Microbial; Equipment Contamination; Eye Diseases; Eye Injuries; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Keratitis; Male; Middle Aged; Occupational Diseases; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Singapore	1995
Botryomycosis caused by Pseudomonas vesicularis. International journal of dermatology, 1996, Volume: 35, Issue:11 Topics: Cefuroxime; Cephalosporins; Hand Dermatoses; Humans; Male; Middle Aged; Pseudomonas Infections	1996
[Antibiotic-induced prolonged cholestasis: suspected induction by ceftibuten]. Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:7 Topics: Adult; Ceftibuten; Cephalosporin Resistance; Cephalosporins; Cholestasis, Intrahepatic; Fatal Outcome; Female; Humans; Liver; Otitis Externa; Pseudomonas Infections; Sepsis	1996
[Spontaneous bacterial peritonitis caused by Pseudomonas aeruginosa]. Gastroenterologia y hepatologia, 1996, Volume: 19, Issue:9 Topics: Ampicillin; Ascitic Fluid; Ceftazidime; Cephalosporins; Enterococcus faecalis; Humans; Male; Middle Aged; Penicillins; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections	1996
Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Animals; Aztreonam; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fibrin; Microbial Sensitivity Tests; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens	1997
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3 Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections	1997
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa. The Journal of antibiotics, 1997, Volume: 50, Issue:2 Topics: Animals; Carbapenems; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Male; Meropenem; Mice; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1997
Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem. Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:2 Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Follow-Up Studies; Imipenem; Injections; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Swine; Thienamycins; Vitreous Body	1997
Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis. The Journal of small animal practice, 1997, Volume: 38, Issue:6 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Buffers; Cephaloridine; Cephalosporins; Cystitis; Dermatitis; Dog Diseases; Dogs; Drug Synergism; Edetic Acid; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Male; Otitis; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Time Factors; Tromethamine	1997
Serum bactericidal activity of ceftazidime administered as continuous infusion of 3 g over 24 h versus intermittent bolus infusion of 2 g against Pseudomonas aeruginosa in healthy volunteers. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:6 Topics: Ceftazidime; Cephalosporins; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Serum Bactericidal Test	1997
Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis. Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:5 Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pseudomonas Infections; Swine; Vitreous Body	1997
Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis. Laboratory animal science, 1997, Volume: 47, Issue:6 Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss	1997
Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Canadian journal of microbiology, 1997, Volume: 43, Issue:11 Topics: Anti-Bacterial Agents; Biofilms; Bronchi; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Time Factors	1997
Corneal ulcer associated with contamination of aerosol saline spray tip. American journal of ophthalmology, 1997, Volume: 124, Issue:3 Topics: Aerosols; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Chloride; Tobramycin	1997
Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum beta-lactamases. Journal of clinical microbiology, 1998, Volume: 36, Issue:3 Topics: beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Humans; Mutation; Nucleic Acid Hybridization; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections	1998
Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:3 Pt 1 Topics: Bacterial Proteins; Bronchi; Cephalosporins; Cohort Studies; Critical Care; DNA, Bacterial; Environmental Microbiology; Female; Follow-Up Studies; Forecasting; Humans; Incidence; Length of Stay; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Multivariate Analysis; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Risk Factors; Sputum; Ventilators, Mechanical	1998
Chemotactic factors in bronchial secretions of cystic fibrosis patients. The Journal of infectious diseases, 1998, Volume: 177, Issue:5 Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Bronchi; Bronchoalveolar Lavage Fluid; Cephalosporins; Chemotactic Factors; Chemotaxis, Leukocyte; Child; Chromatography, Gel; Cystic Fibrosis; Drug Therapy, Combination; Humans; Middle Aged; Pseudomonas Infections; Sputum	1998
An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:4 Topics: Ceftazidime; Cephalosporins; Endotoxins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1998
[Therapeutic effect of cefluprenam on polymicrobial urinary tract infection associated with Enterococcus faecalis, using the infectious urolithiasis model in rats]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1998, Volume: 72, Issue:4 Topics: Animals; Ceftazidime; Cephalosporins; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Calculi; Urinary Tract Infections	1998
[Meningitis caused by Pseudomonas aeruginosa. Treatment with meropenem]. Enfermedades infecciosas y microbiologia clinica, 1998, Volume: 16, Issue:5 Topics: Aged; Blood-Brain Barrier; Cefepime; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Hydrocephalus; Male; Meningitis, Bacterial; Meropenem; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1998
Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Pseudomonas aeruginosa; Pseudomonas Infections; Turkey	1998
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime. Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:2 Topics: Bacteremia; Cefepime; Cephalosporins; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Reference Standards; Reproducibility of Results; Sensitivity and Specificity	1998
Neonatal Pseudomonas putida infection presenting as staphylococcal scalded skin syndrome. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:9 Topics: Ceftazidime; Cephalosporins; Diagnosis, Differential; Fatal Outcome; Humans; Infant, Newborn; Male; Pseudomonas Infections; Pseudomonas putida; Skin Diseases, Bacterial; Staphylococcal Scalded Skin Syndrome	1998
Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin. International journal of antimicrobial agents, 1998, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Carbenicillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Geography; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections	1998
Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:11 Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1998
Infectious dermatitis in a ball python (Python regius) colony. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 1998, Volume: 29, Issue:4 Topics: Amikacin; Animals; Anti-Bacterial Agents; Boidae; Cefotaxime; Cephalosporins; Dermatitis; Disease Outbreaks; Fatal Outcome; Female; Male; Proteus Infections; Proteus vulgaris; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious	1998
Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. Infection control and hospital epidemiology, 1999, Volume: 20, Issue:3 Topics: Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Hospitals, Teaching; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Taiwan	1999
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient. Anaesthesia and intensive care, 1999, Volume: 27, Issue:2 Topics: Adult; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Gentamicins; Humans; Immunocompetence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial	1999
A resuscitated case from asphyxia by large bronchial cast. The Tohoku journal of experimental medicine, 1999, Volume: 187, Issue:2 Topics: Airway Obstruction; Asphyxia; Bronchial Diseases; Bronchiectasis; Bronchopneumonia; Bronchoscopy; Ceftazidime; Cephalosporins; Female; Humans; Middle Aged; Pseudomonas Infections; Radiography, Thoracic; Resuscitation; Suction; Tomography, X-Ray Computed; Treatment Outcome	1999
Bilateral Pseudomonas corneal ulcer in a disposable contact lens wearer. The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc, 1999, Volume: 25, Issue:2 Topics: Adolescent; Cephalosporins; Cephalothin; Contact Lenses, Hydrophilic; Cornea; Corneal Ulcer; Disposable Equipment; Drug Therapy, Combination; Eye Infections, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Ophthalmic Solutions; Patient Education as Topic; Pseudomonas aeruginosa; Pseudomonas Infections	1999
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1999, Volume: 107, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	1999
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar	1999
Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:12 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Therapy, Combination; Humans; Mice; Pneumonia, Bacterial; Pseudomonas Infections; Survival Analysis; Time Factors; Urinary Tract Infections	1999
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1 Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	2000
Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3 Topics: Ampicillin; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Enzyme Induction; Genetic Complementation Test; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; N-Acetylmuramoyl-L-alanine Amidase; Penicillins; Phenotype; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA	2000
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. International journal of antimicrobial agents, 2000, Volume: 14, Issue:1 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Forecasting; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Time Factors	2000
Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronic suppurative otitis media due to Pseudomonas aeruginosa. Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:1 Topics: Ambulatory Care; Ceftazidime; Cephalosporins; Child; Chronic Disease; Female; Humans; Injections, Intramuscular; Male; Otitis Media, Suppurative; Patient Compliance; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2000
Aminoglycosides and renal magnesium homeostasis in humans. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Electrolytes; Female; Homeostasis; Humans; Kidney; Lung Diseases; Magnesium; Male; Pseudomonas aeruginosa; Pseudomonas Infections	2000
Status epilepticus associated with cefepime. Neurology, 2000, Jun-13, Volume: 54, Issue:11 Topics: Adult; Cefepime; Cephalosporins; Electroencephalography; Female; Humans; Male; Pseudomonas Infections; Status Epilepticus	2000
Treatment of peritoneal dialysis related peritonitis--an Australian and New Zealand perspective. Australian and New Zealand journal of medicine, 1999, Volume: 29, Issue:4 Topics: Algorithms; Anti-Bacterial Agents; Australia; Catheterization; Cephalosporins; Humans; New Zealand; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Vancomycin	1999
Filamented Pseudomonas aeruginosa and a markedly high level of endotoxin in cerebrospinal fluid. The Journal of infection, 2000, Volume: 41, Issue:1 Topics: Adult; Cefozopran; Cephalosporins; Cerebrospinal Fluid; Endotoxins; Fatal Outcome; Humans; Japan; Male; Meningitis, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections	2000
Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime. Microbiology and immunology, 2000, Volume: 44, Issue:8 Topics: Animals; Antibodies, Monoclonal; Ceftazidime; Cephalosporins; Combined Modality Therapy; Disease Models, Animal; Female; Humans; Immunoglobulin G; Immunoglobulins; Lipopolysaccharides; Mice; Neutrophils; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Thigh	2000
Pharmacokinetics of ceftazidime in dogs following subcutaneous administration and continuous infusion and the association with in vitro susceptibility of Pseudomonas aeruginosa. American journal of veterinary research, 2000, Volume: 61, Issue:10 Topics: Animals; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Disease Susceptibility; Dog Diseases; Dogs; Infusions, Intravenous; Injections, Subcutaneous; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2000
[Malignant or necrotizing otitis externa: experience in 22 cases]. Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 2000, Volume: 117, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cephalosporins; Diabetes Complications; Disease Progression; Drug Therapy, Combination; Female; Fluoroquinolones; Gallium Radioisotopes; Humans; Hyperbaric Oxygenation; Immunocompromised Host; Male; Middle Aged; Otitis Externa; Pseudomonas Infections; Recurrence; Retrospective Studies; Technetium; Tomography, X-Ray Computed; Treatment Outcome	2000
Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection. The Journal of trauma, 2000, Volume: 49, Issue:5 Topics: Animals; Burns; Ceftazidime; Cephalosporins; Combined Modality Therapy; Cross Infection; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Female; Immunoglobulins, Intravenous; Infusions, Intravenous; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Pseudomonas Infections; Survival Analysis; Wound Infection	2000
Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2000, Volume: 108, Issue:9 Topics: Animals; Bacterial Proteins; beta-Lactamases; Biofilms; Ceftazidime; Cephalosporins; Chromosomes, Bacterial; Chronic Disease; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Isoelectric Focusing; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pregnancy; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Lew; Time Factors	2000
Cavernous sinus thrombosis complicating odontogenic parapharyngeal space neck abscess: a case report and discussion. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2000, Volume: 123, Issue:6 Topics: Aged; Anti-Infective Agents; Cavernous Sinus Thrombosis; Ceftriaxone; Cephalosporins; Combined Modality Therapy; Diplopia; Drainage; Drug Therapy, Combination; Exophthalmos; Humans; Male; Metronidazole; Nafcillin; Ophthalmoplegia; Penicillins; Periodontal Abscess; Pseudomonas Infections; Retropharyngeal Abscess; Tomography, X-Ray Computed	2000
Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children. European journal of pediatrics, 2000, Volume: 159, Issue:12 Topics: Adolescent; Ceftazidime; Cephalosporins; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Female; Humans; Infusion Pumps; Male; Microbial Sensitivity Tests; Nutritional Status; Pseudomonas Infections	2000
Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz. The Journal of antibiotics, 2000, Volume: 53, Issue:10 Topics: Animals; Cefozopran; Cephalosporins; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oximes; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship	2000
Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz. The Journal of antibiotics, 2000, Volume: 53, Issue:10 Topics: Animals; Cefozopran; Cephalosporins; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship	2000
Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Pediatric pulmonology, 2001, Volume: 31, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Body Mass Index; Cephalosporins; Chemoprevention; Child; Child, Preschool; Cystic Fibrosis; Databases as Topic; Forced Expiratory Volume; Humans; Infant; Lung; Macrolides; Pseudomonas aeruginosa; Pseudomonas Infections; Registries; Staphylococcal Infections; Staphylococcus aureus; Statistics, Nonparametric; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vital Capacity	2001
Urinary tract infection in neurogenic bladder. International journal of antimicrobial agents, 2001, Volume: 17, Issue:4 Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections	2001
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. Journal of clinical microbiology, 2001, Volume: 39, Issue:5 Topics: beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Intensive Care Units; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections	2001
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance. Journal of clinical microbiology, 2001, Volume: 39, Issue:6 Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping	2001
Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney international, 2001, Volume: 59, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Equipment Contamination; Female; Gentamicins; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pseudomonas Infections; Retrospective Studies; Secondary Prevention; Vancomycin	2001
Post-antibiotic and synergic effects of fluoroquinolones and ceftazidime in combination against Pseudomonas strains. Acta biologica Hungarica, 2001, Volume: 52, Issue:2-3 Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Comamonas testosteroni; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections	2001
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam	2001
CF and antistaphylococcal prophylaxis. Thorax, 2001, Volume: 56, Issue:10 Topics: Cephalexin; Cephalosporins; Child; Cystic Fibrosis; Humans; Infant; Pseudomonas Infections; Staphylococcal Infections	2001
[Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanisms: the GERPB 1999 study]. Pathologie-biologie, 2001, Volume: 49, Issue:7 Topics: Academic Medical Centers; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporinase; Cephalosporins; Chromosomes, Bacterial; Drug Resistance; France; Humans; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors; Serotyping	2001
Sepsis in a newborn due to Pseudomonas aeruginosa from a contaminated tub bath. The New England journal of medicine, 2001, Nov-29, Volume: 345, Issue:22 Topics: Ampicillin; Anti-Bacterial Agents; Baths; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Pseudomonas aeruginosa; Pseudomonas Infections	2001
In vivo selection of oxacillinase-mediated ceftazidime resistance in Pseudomonas aeruginosa. Microbial drug resistance (Larchmont, N.Y.), 2001,Fall, Volume: 7, Issue:3 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carrier Proteins; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections	2001
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia. Chemotherapy, 2001, Volume: 47, Issue:6 Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins	2001
Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Mar-01, Volume: 34, Issue:5 Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Frequency; Humans; Integrases; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand; Transduction, Genetic	2002
Emergence of new pathogens in CF: the devil we know or the devil we don't know? The Journal of pediatrics, 2002, Volume: 140, Issue:3 Topics: Antibiotic Prophylaxis; Cephalexin; Cephalosporins; Cystic Fibrosis; Humans; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas Infections	2002
Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fluoroquinolones; Global Health; Humans; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections	2002
In-vitro activity of new cephalosporin (HR 756) and cefazolin. Lancet (London, England), 1978, Sep-02, Volume: 2, Issue:8088 Topics: Cefazolin; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Humans; In Vitro Techniques; Pseudomonas aeruginosa; Pseudomonas Infections	1978
[Therapy of chronic respiratory tract infections in children, including mucoviscidosis (author's transl)]. Infection, 1979, Volume: 7 Suppl 6 Topics: Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Combinations; Humans; Infant; Infant, Newborn; Long-Term Care; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1979
Antibiotic treatment of respiratory sepsis. Antibiotics and chemotherapy, 1976, Volume: 21 Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Cloxacillin; Fosfomycin; Gentamicins; Haemophilus Infections; Humans; Methicillin; Penicillin G; Polymyxins; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections	1976
Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1978, Volume: 14, Issue:1 Topics: Animals; Cephalosporins; Gentamicins; Mice; Penicillin G; Penicillin Resistance; Pseudomonas Infections; Sulbenicillin	1978
[Azlocilline and HR 756 in urosepsis and urinary tract infection with multiresistant pseudomonas and proteus morganii]. Deutsche medizinische Wochenschrift (1946), 1979, Jan-12, Volume: 104, Issue:2 Topics: Adolescent; Cephalosporins; Female; Humans; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections	1979
Common bacterial infections in infancy and childhood. 5. Infections of the skeletal system. Drugs, 1978, Volume: 16, Issue:3 Topics: Arthritis, Infectious; Bacterial Infections; Cephalosporins; Child; Chloramphenicol; Female; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Osteomyelitis; Penicillins; Pseudomonas Infections; Staphylococcal Infections	1978
[Progress in antibacterial chemotherapy]. Der Internist, 1978, Volume: 19, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas Infections	1978
[New antibiotics]. Wiener medizinische Wochenschrift (1946), 1979, Jul-15, Volume: 129, Issue:14 Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Gram-Negative Aerobic Bacteria; Humans; Klebsiella Infections; Penicillin Resistance; Penicillins; Pseudomonas Infections; Sepsis	1979
SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrobial agents and chemotherapy, 1978, Volume: 13, Issue:2 Topics: Animals; Bacterial Proteins; Cephalosporins; Depression, Chemical; DNA, Bacterial; Drug Resistance, Microbial; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; RNA, Bacterial; Staphylococcus aureus	1978
Antibiotics in pyelonephritis. Contributions to nephrology, 1979, Volume: 16 Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Proteus Infections; Pseudomonas Infections; Pyelonephritis	1979
Clinical experience with cefamandole for treatment of serious bone and joint infections. The Journal of infectious diseases, 1978, Volume: 137 Suppl Topics: Adolescent; Adult; Aged; Arthritis, Infectious; Bacterial Infections; Bacteroides Infections; Bursitis; Cefamandole; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Surgical Wound Infection	1978
Evaluation of antibiotic efficacy using electron microscopy: morphological effects of guanylureido cephalosporin, chlorobenzoylureido cephalosporin, BL-P1654, and carbenicillin on Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1976, Volume: 9, Issue:2 Topics: Animals; Carbenicillin; Cephalosporins; Chlorobenzoates; Guanidines; Leucine; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections	1976
Urinary infections in total hip arthroplasty. Influences of prophylactic cephalosporins and catheterization. The Journal of bone and joint surgery. American volume, 1976, Volume: 58, Issue:8 Topics: Arthroplasty; Cephalosporins; Enterobacteriaceae Infections; Female; Hip; Humans; Male; Pseudomonas Infections; Surgical Wound Infection; Urinary Catheterization; Urinary Tract Infections	1976
[The bacterial infections in patients with acute leukemia and their treatment by antibiotics, with special reference to Klebsiella and Pseudomonas infections (author's transl)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1975, Volume: 16, Issue:7 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Humans; Klebsiella Infections; Leukemia; Male; Penicillins; Pseudomonas Infections	1975
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12 Topics: Amikacin; Aztreonam; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Half-Life; Humans; In Vitro Techniques; Pseudomonas Infections	1992
Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: Animals; Ceftazidime; Cephalosporins; Drug Evaluation, Preclinical; Female; Injections, Intramuscular; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Urinary Calculi; Urinary Tract Infections	1992
Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model. The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:5 Topics: Animals; Cefepime; Ceftazidime; Cephalosporins; Citrobacter freundii; Disease Models, Animal; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia Infections; Serratia marcescens; Virulence	1992
[Multiply resistant Pseudomonas aeruginosa in the pediatric field]. Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:10 Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Monobactams; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones	1991
[Diagnosis and therapy of pneumonia caused by gram-negative bacillus including legionella]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, May-10, Volume: 80, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Haemophilus Infections; Humans; Klebsiella Infections; Legionnaires' Disease; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections	1991
Comparative therapy with cefpirome alone and in combination with rifampin and/or gentamicin against a disseminated Pseudomonas aeruginosa infection in leukopenic mice. The Journal of infectious diseases, 1990, Volume: 162, Issue:5 Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Kidney; Leukopenia; Liver; Lung; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Spleen	1990
A new antipseudomonal cephalosporin CP6162 and its congeners. The Journal of antibiotics, 1990, Volume: 43, Issue:11 Topics: Animals; Bacteria; Cephalosporins; Chromatography, Thin Layer; Magnetic Resonance Spectroscopy; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Stereoisomerism	1990
[Pathogenic and clinical changes of pneumonia in the recent 10 years]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1990, Volume: 13, Issue:6 Topics: Adult; Cephalosporins; Drug Resistance, Microbial; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections	1990
New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. I. Synthesis and biological activity of cephalosporin derivatives leading to MT0703. The Journal of antibiotics, 1990, Volume: 43, Issue:2 Topics: Animals; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Klebsiella Infections; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Spectrophotometry; Structure-Activity Relationship	1990
New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. II. Synthesis and antibacterial activity of MT0703 and its diastereomers. The Journal of antibiotics, 1990, Volume: 43, Issue:2 Topics: Animals; Cephalosporins; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Escherichia coli Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship	1990
Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:1 Topics: Animals; Cefpirome; Cephalosporins; Escherichia coli; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Methicillin; Mice; Penicillin Resistance; Pseudomonas Infections; Pyelonephritis; Rats; Staphylococcal Infections; Staphylococcus aureus; Uterine Diseases	1990
[Pulmonary Pseudomonas infections]. Zhonghua nei ke za zhi, 1990, Volume: 29, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Pseudomonas; Pseudomonas Infections; Respiratory Insufficiency	1990
[Cephalosporins in the treatment of urinary tract infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1990, Volume: 35, Issue:8 Topics: Cephalosporins; Drug Evaluation; Enterobacteriaceae Infections; Humans; Pseudomonas Infections; Urinary Tract Infections	1990
A new aminothiazolylcephalosporin having 1-carboxyethoxyimino group, ME1228. The Journal of antibiotics, 1990, Volume: 43, Issue:1 Topics: Animals; Bacteria; Bacterial Infections; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Isomerism; Male; Mice; Mice, Inbred ICR; Pseudomonas Infections	1990
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa. The Journal of antibiotics, 1989, Volume: 42, Issue:5 Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	1989
Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:4 Topics: Bacterial Infections; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Gram-Negative Bacteria; Isoelectric Focusing; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	1989
In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:9 Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	1989
Management of osteomyelitis of the skull base. The Laryngoscope, 1989, Volume: 99, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Gallium Radioisotopes; Humans; Osteomyelitis; Otitis Externa; Penicillins; Pseudomonas Infections; Radionuclide Imaging; Skull; Technetium	1989
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals. The Journal of antibiotics, 1989, Volume: 42, Issue:5 Topics: Animals; Bacterial Infections; Ceftazidime; Cephalosporins; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Half-Life; Isoindoles; Macaca mulatta; Male; Mice; Neutropenia; Pseudomonas Infections	1989
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat. The Journal of infectious diseases, 1986, Volume: 153, Issue:4 Topics: Animals; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rats; Rats, Inbred Strains; Time Factors	1986
[Current aspects of pseudomonas meningitis]. Neurochirurgia, 1985, Volume: 28, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacteriological Techniques; Brain Injuries; Cefsulodin; Cephalosporins; Diagnosis, Differential; Fosfomycin; Humans; Meningitis; Penicillins; Polymyxins; Pseudomonas Infections	1985
Clinical consequences of development of resistance to third generation cephalosporins. European journal of clinical microbiology, 1987, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aged; Cephalosporins; Child; Citrobacter; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Immune Tolerance; Klebsiella; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens	1987
Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice. The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:4 Topics: Agranulocytosis; Animals; Cephalosporins; Ciprofloxacin; Cyclophosphamide; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections	1987
Therapeutic efficacy of cefpiramide and cefoperazone alone and in combination with gentamicin against pseudomonal infections in neutropenic mice. Chemotherapy, 1986, Volume: 32, Issue:2 Topics: Animals; Cefoperazone; Cephalosporins; Cyclophosphamide; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Female; Gentamicins; Half-Life; Injections, Intraperitoneal; Injections, Subcutaneous; Kinetics; Lethal Dose 50; Mice; Neutropenia; Pseudomonas Infections	1986
Effect of inflammation on antibiotic penetration into the anterior segment of the rat eye. Investigative ophthalmology & visual science, 1986, Volume: 27, Issue:6 Topics: Administration, Topical; Animals; Anterior Eye Segment; Anti-Bacterial Agents; Cephalosporins; Cephradine; Gentamicins; Injections, Intravenous; Keratitis; Male; Permeability; Pseudomonas Infections; Rats; Rats, Inbred Strains; Staphylococcal Infections	1986
Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections. Drugs under experimental and clinical research, 1986, Volume: 12, Issue:4 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Burns; Cephalosporins; Female; Mice; Naphthyridines; Pseudomonas Infections; Wound Infection	1986
A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid. Archives of ophthalmology (Chicago, Ill. : 1960), 1985, Volume: 103, Issue:5 Topics: Animals; Bacterial Infections; Cephalosporins; Cephradine; Disease Models, Animal; Drug Therapy, Combination; Gentamicins; Keratitis; Leukocyte Count; Penicillin G; Prednisolone; Pseudomonas Infections; Rats; Staphylococcal Infections; Streptococcal Infections	1985
Multistrain comparison of three antimicrobial prophylaxis regimens in experimental postoperative Pseudomonas endophthalmitis. American journal of ophthalmology, 1985, Sep-15, Volume: 100, Issue:3 Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Evaluation, Preclinical; Eye Diseases; Gentamicins; Inflammation; Postoperative Period; Pseudomonas Infections; Rabbits	1985
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:2 Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis	1985
[HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin]. Pathologie-biologie, 1985, Volume: 33, Issue:5 Pt 2 Topics: Animals; Bacterial Infections; Cefpirome; Cephalosporins; Citrobacter; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Klebsiella Infections; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Salmonella Infections, Animal; Salmonella typhimurium; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes	1985
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin. Drugs under experimental and clinical research, 1985, Volume: 11, Issue:11 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Female; Kinetics; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Staphylococcal Infections	1985
Use of aminoglycosides in immunocompromised patients. The American journal of medicine, 1985, Jul-15, Volume: 79, Issue:1A Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Immune Tolerance; Infusions, Parenteral; Kidney Diseases; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Sepsis	1985
Diagnosis and management of infections associated with immunosuppression. New antibiotics of potential importance for immunosuppressed patients. Transplantation proceedings, 1973, Volume: 5, Issue:3 Topics: Amino Sugars; Bacteria; Carbenicillin; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Escherichia coli Infections; Glycosides; Immunization, Passive; Immunosuppression Therapy; Kanamycin; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Structure-Activity Relationship	1973
Antibiotics, 1972. Clinical pediatrics, 1972, Volume: 11, Issue:12 Topics: Amino Sugars; Anti-Bacterial Agents; Bacteria; Candidiasis; Carbenicillin; Cephalosporins; Cryptococcosis; Drug Synergism; Flucytosine; Glycosides; Gonorrhea; Humans; Meningococcal Infections; Minocycline; Pseudomonas Infections; Spectinomycin; Sulfonamides; Tetracycline; Trimethoprim	1972
[The incidence of infection in orthopedic and traumatologic operations (author's transl)]. Zeitschrift fur Orthopadie und ihre Grenzgebiete, 1973, Volume: 111, Issue:6 Topics: Arthritis, Infectious; Cephalosporins; Cloxacillin; Dicloxacillin; Germany, West; Humans; Kanamycin; Lincomycin; Orthopedics; Osteomyelitis; Oxacillin; Penicillin G; Penicillin Resistance; Penicillin V; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Surgical Wound Infection; Tetracycline	1973
[Chemotherapy and chemoprophylaxis of surgical infections]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1967, Volume: 38, Issue:4 Topics: Bacteria; Cephalosporins; Chloramphenicol; Drug Antagonism; Drug Incompatibility; Humans; Infections; Nitrofurantoin; Penicillin G; Penicillin Resistance; Penicillins; Polymyxins; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Sulfonamides; Surgical Wound Infection; Tetracycline	1967
Antimicrobial drugs for treatment of infections caused by aerobic gram-negative bacilli. The Medical clinics of North America, 1974, Volume: 58, Issue:3 Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cephalosporins; Chloramphenicol; Dysentery, Bacillary; Escherichia coli Infections; Gentamicins; Haemophilus Infections; Humans; Kanamycin; Klebsiella Infections; Polymyxins; Proteus Infections; Pseudomonas Infections; Salmonella Infections; Sulfonamides; Tetracycline	1974
Correlations between in vitro sensitivity testing and therapeutic response in urinary tract infections. Urology, 1973, Volume: 2, Issue:5 Topics: Bacteriuria; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas Infections; Statistics as Topic; Urinary Tract Infections	1973
[Antibacterial chemotherapy of the chronic bronchitis syndrome]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1974, Feb-01, Volume: 29, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Carbenicillin; Cephalosporins; Chloramphenicol; Chronic Disease; Drug Synergism; Escherichia coli Infections; Gentamicins; Humans; Penicillin G; Pseudomonas Infections; Staphylococcal Infections; Sulfonamides; Syndrome; Tetracycline; Trimethoprim	1974
[Urosepsis in urinary calculi]. Helvetica chirurgica acta, 1974, Volume: 41, Issue:3 Topics: Adult; Ampicillin; Carbenicillin; Cephalosporins; Drug Therapy, Combination; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Male; Nephrectomy; Proteus Infections; Pseudomonas Infections; Sepsis; Urinary Calculi	1974
Venous perfusion of the limb with antibiotics for osteomyelitis and other chronic infections. The Journal of bone and joint surgery. American volume, 1972, Volume: 54, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bone and Bones; Catheterization; Cephalosporins; Chronic Disease; Drainage; Erythromycin; Femur; Follow-Up Studies; Humans; Humerus; Injections, Intravenous; Leg; Methicillin; Middle Aged; Osteomyelitis; Penicillins; Perfusion; Pressure; Pseudomonas Infections; Radiography; Recurrence; Staphylococcal Infections; Streptococcal Infections; Tourniquets	1972
Cephacetrile--a new cephalosporin antibiotic. International journal of clinical pharmacology, therapy and toxicology, 1973, Volume: 7, Issue:1 Topics: Adult; Bacterial Infections; Cephalosporins; Drug Interactions; Female; Furosemide; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Male; Microbial Sensitivity Tests; Pneumonia; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections	1973
Recent developments in the treatment of infectious diseases. II. Alternatives to penicillin in the treatment of infections caused by gram-positive organisms. Missouri medicine, 1971, Volume: 68, Issue:6 Topics: Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Humans; Infections; Lincomycin; Penicillins; Protozoan Infections; Pseudomonas Infections; Salmonella Infections; Staphylococcal Infections	1971
The newer antibiotics: some therapeutic considerations. The Journal of the Kentucky Medical Association, 1972, Volume: 70, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalexin; Cephaloglycin; Cephalosporins; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Rifampin; Staphylococcal Infections	1972
[Clinical results of the use of cephaloridine in lung diseases, especially pulmonary tuberculosis]. The Journal of antibiotics. Ser. B, 1967, Volume: 20, Issue:2 Topics: Adult; Bronchiectasis; Cephaloridine; Cephalosporins; Empyema, Tuberculous; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pseudomonas Infections; Respiratory Therapy; Sputum; Tuberculosis, Pulmonary	1967
Recent advances in chemotherapy. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1968, Jan-20, Volume: 42, Issue:3 Topics: Bacteroides Infections; Cephalosporins; Drug Therapy; Enterobacteriaceae Infections; Haemophilus Infections; Humans; Lincomycin; Penicillins; Pneumococcal Infections; Pseudomonas Infections; Staphylococcal Infections	1968